SUSAN G KOMEN BREAST CANCER FOUNDATION: Form 990, tax year 2017
View the entire original 990 at ProPublica ↗
- Organization
- SUSAN G KOMEN BREAST CANCER FOUNDATION (EIN 75-1835298)
- Tax period
- 2017-04-01 to 2018-03-31
- Filed
- 2018-12-14
- IRS object ID
- 201843489349301169
- Schema version
- 2017v2.3
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule M
- Schedule O
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2018-12-14T17:35:07-06:00 | ReturnTs |
| Tax Period End | 2018-03-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ERNST & YOUNG US LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1901 6TH AVE N | AddressLine1Txt |
| City | BIRMINGHAM | CityNm |
| State Abbreviation | AL | StateAbbreviationCd |
| ZIP | 35203 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2017-04-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 751835298 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | SUSAN G KOMEN BREAST CANCER FDN INC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % RIA WILLIAMS | InCareOfNm |
| Business Name Control | SUSA | BusinessNameControlTxt |
| Phone | 9728551600 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 5005 LBJ Freeway suite 526 | AddressLine1Txt |
| City | Dallas | CityNm |
| State Abbreviation | TX | StateAbbreviationCd |
| ZIP | 752446125 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | PAULA SUE SCHNEIDER | PersonNm |
| Person Title | PRESIDENT AND CEO | PersonTitleTxt |
| Phone | 9728551600 | PhoneNum |
| Signature | 2018-12-14 | SignatureDt |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | KATHY PITTS | PreparerPersonNm |
| PTIN | P00292940 | PTIN |
| Phone | 2052260027 | PhoneNum |
Filing Security Information FilingSecurityInformation
IP Address IPAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| I Pv4 Address | 97.77.198.2 | IPv4AddressTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Federal Original Submission Id | 75306120183485000015 | FederalOriginalSubmissionId |
| Federal Original Submission Id | 2018-12-14 | FederalOriginalSubmissionIdDt |
| Filing License Type | P | FilingLicenseTypeCd |
| At Submission Creation Device Id | EFEC630553F7A05BD707F6467E755DCD1324F206 | AtSubmissionCreationDeviceId |
| At Submission Filing Device Id | 69C071E2F2C5E195884386C1B3C530989D25512E | AtSubmissionFilingDeviceId |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2017 | TaxYr |
| Build TS | 2019-02-21 02:37:17Z | BuildTS |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Susan G Komen | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | Paula Sue Schneider | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 5005 LBJ Freeway Suite 526 | AddressLine1Txt |
| City | Dallas | CityNm |
| State Abbreviation | TX | StateAbbreviationCd |
| ZIP | 752446125 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $109,982,784 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Group Exemption | 7164 | GroupExemptionNum |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | www.komen.org | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1982 | FormationYr |
| Legal Domicile State | TX | LegalDomicileStateCd |
| Activity Or Mission | OUR MISSION IS TO SAVE LIVES BY MEETING THE MOST CRITICAL NEEDS IN OUR COMMUNITIES AND INVESTING IN BREAKTHROUGH RESEARCH TO PREVENT AND CURE BREAST CANCER. | ActivityOrMissionDesc |
| Voting Members Governing Body | 14 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 14 | VotingMembersIndependentCnt |
| Total Employee | 245 | TotalEmployeeCnt |
| Total Volunteers | 2640 | TotalVolunteersCnt |
| Total Gross UBI | $6,100 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | -$14,562 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $55,634,984 | PYContributionsGrantsAmt |
| CY Contributions Grants | $51,441,732 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $15,856,597 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $14,437,717 | CYProgramServiceRevenueAmt |
| PY Investment Income | $3,758,190 | PYInvestmentIncomeAmt |
| CY Investment Income | $14,239,081 | CYInvestmentIncomeAmt |
| PY Other Revenue | -$4,906,867 | PYOtherRevenueAmt |
| CY Other Revenue | -$3,380,561 | CYOtherRevenueAmt |
| PY Total Revenue | $70,342,904 | PYTotalRevenueAmt |
| CY Total Revenue | $76,737,969 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $35,357,025 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $28,995,790 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $24,717,739 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $21,442,628 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $2,584,720 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $1,118,493 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $11,817,989 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $36,543,700 | PYOtherExpensesAmt |
| CY Other Expenses | $31,719,529 | CYOtherExpensesAmt |
| PY Total Expenses | $99,203,184 | PYTotalExpensesAmt |
| CY Total Expenses | $83,276,440 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$28,860,280 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$6,538,471 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $220,522,141 | TotalAssetsBOYAmt |
| Total Assets EOY | $201,811,514 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $92,137,738 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $77,405,059 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $128,384,403 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $124,406,455 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | SUSAN G. KOMEN's MISSION IS TO SAVE LIVES BY MEETING THE MOST CRITICAL NEEDS IN OUR COMMUNITIES AND INVESTING IN BREAKTHROUGH RESEARCH TO PREVENT AND CURE BREAST CANCER. | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Activity | 32 | ActivityCd |
| Expense | $34,254,506 | ExpenseAmt |
| Grant | $26,025,613 | GrantAmt |
| Revenue | $14,437,717 | RevenueAmt |
| Desc | GRANTS TO ACADEMIC INSTITUTIONS AND OTHER NONPROFIT ORGANIZATIONS TO SUPPORT BREAST CANCER RESEARCH PROJECTS INCLUDING THOSE FOCUSED ON THE BIOLOGY OF BREAST CANCER; EARLY DETECTION, DIAGNOSIS, AND PREVENTION STRATEGIES; DEVELOPING TARGETED THERAPIES, OVERCOMING BREAST CANCER PROGRESSION, TREATMENT RESISTANCE AND METASTASIS, PREDICTING RISK, DEVELOPING NEW IMAGING TECHNIQUES, AND UNDERSTANDING AND ADDRESSING DISPARITIES IN OUTCOMES AS WELL AS RESEARCH RESOURCES AND CONFERENCES. SEE SCHEDULE O FOR ADDITIONAL DETAILS. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Activity | 32 | ActivityCd |
| Expense | $23,555,222 | ExpenseAmt |
| Grant | $555,547 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | PROVISION OF BREAST HEALTH/CANCER EDUCATION MATERIALS AND PATIENT SUPPORT PROGRAMS, SUCH AS THE KOMEN BREAST CARE HELPLINE, CLINICAL TRIAL INFORMATION HELPLINE, AND TREATMENT ASSISTANCE PROGRAM, WERE MADE POSSIBLE DIRECTLY BY KOMEN AND THROUGH GRANTS TO OTHER NONPROFIT ORGANIZATIONS TO INCREASE THE PUBLIC'S KNOWLEDGE OF BREAST CANCER, ITS RISK FACTORS, THE IMPORTANCE OF EARLY DETECTION, METASTATIC BREAST CANCER, TREATMENT, SOCIAL SUPPORT, AND INFORMATION ABOUT COMMUNITY RESOURCES. SEE SCHEDULE O FOR ADDITIONAL DETAILS. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Activity | 32 | ActivityCd |
| Expense | $5,917,427 | ExpenseAmt |
| Grant | $2,414,630 | GrantAmt |
| Revenue | $1,387,402 | RevenueAmt |
| Desc | GRANTS TO OTHER NONPROFIT ORGANIZATIONS TO SUPPORT BREAST CANCER SCREENING, DIAGNOSIS, AND TREATMENT PROGRAMS WITH A SPECIAL EMPHASIS ON PATIENT NAVIGATION, ESPECIALLY IN COMMUNITIES WHERE DISPARITIES IN OUTCOMES ARE SIGNIFICANT AND/OR ACCESS IS LIMITED. SEE SCHEDULE O FOR ADDITIONAL DETAILS. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $63,727,155 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (true) | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Temp Or Permanent Endowments | Yes (true) | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | Yes (true) | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | false | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | false | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (true) | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | false | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (true) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | Yes (true) | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (true) | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | false | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | Yes (true) | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | false | RelatedEntityInd |
| Related Organization Ctrl Ent | false | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 71 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 245 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | Yes (true) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (true) | Form990TFiledInd |
| Foreign Financial Account | false | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (true) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (true) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 14 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 14 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | false | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | false | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | Yes (true) | LocalChaptersInd |
| Policies Reference Chapters | Yes (true) | PoliciesReferenceChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AZ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | DC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | HI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ME | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ND | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | RIA WILLIAMS | PersonNm |
| Phone | 9728551600 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 5005 LBJ Freeway Suite 526 | AddressLine1Txt |
| City | Dallas | CityNm |
| State Abbreviation | TX | StateAbbreviationCd |
| ZIP | 75244 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (32 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd | Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd |
|---|---|---|---|---|---|---|---|---|---|---|
| Connie O'Neill | ||||||||||
| Chair of the Board | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | |||
| Linda Custard | ||||||||||
| BOARD MEMBER | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| Jane Abraham | ||||||||||
| BOARD MEMBER | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| Alan Feld | ||||||||||
| BOARD MEMBER | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| Dr Olufunmilayo Olopade | ||||||||||
| BOARD MEMBER | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| Janet Dunn Frantz | ||||||||||
| BOARD MEMBER | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| Dan Glennon | ||||||||||
| BOARD MEMBER and Treasurer | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | |||
| Melissa Maxfield | ||||||||||
| BOARD MEMBER | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| Meghan Shannon | ||||||||||
| BOARD MEMBER | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| Trish Wheaton | ||||||||||
| BOARD MEMBER | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| Angela Zepeda | ||||||||||
| BOARD MEMBER | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| Kim Bohr | ||||||||||
| BOARD MEMBER (Beg. 6/17) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| Peter D Brundage | ||||||||||
| BOARD MEMBER (Beg. 6/17) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| Andrew Robinson | ||||||||||
| BOARD MEMBER (Beg. 6/17) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| Linda Wilkins | ||||||||||
| BOARD MEMBER (End 6/17) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| Kaye Ceille | ||||||||||
| BOARD MEMBER (End 6/17) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||||
| Paula Schneider | ||||||||||
| President and CEO (Beg. 10/17) | 55.0 | 0.0 | Yes (X) | $137,155 | $0 | $6,155 | ||||
| Robert Green | ||||||||||
| Chief Financial Officer | 55.0 | 0.0 | Yes (X) | $284,384 | $0 | $10,809 | ||||
| Adam Vanek BEG 417 | ||||||||||
| Gen. Counsel & Asst Corp Secy | 55.0 | 0.0 | Yes (X) | $166,163 | $0 | $23,926 | ||||
| Ellen Willmott | ||||||||||
| INTERIM CEO (END 10/17) | 55.0 | 0.0 | Yes (X) | $380,456 | $0 | $26,839 | ||||
| Lesley Lurie END 417 | ||||||||||
| Deputy Counsel & Assist Secy | 55.0 | 0.0 | Yes (X) | $95,097 | $0 | $16,737 | ||||
| Christina Alford | ||||||||||
| SVP, Development | 55.0 | 0.0 | $282,288 | $0 | $19,315 | Yes (X) | ||||
| Victoria Wolodzko | ||||||||||
| VP Research and Com. Health Pr | 55.0 | 0.0 | $185,526 | $0 | $21,607 | Yes (X) | ||||
| Lori Maris | ||||||||||
| SVP, Affiliate Network | 55.0 | 0.0 | $170,432 | $0 | $18,785 | Yes (X) | ||||
| Eric Montgomery | ||||||||||
| VP, I.T. | 55.0 | 0.0 | $194,143 | $0 | $46,653 | Yes (X) | ||||
| Catherine Olivieri | ||||||||||
| VP, Human Resources | 55.0 | 0.0 | $218,036 | $0 | $52,214 | Yes (X) | ||||
| Andrea Rader | ||||||||||
| Sr Dir, Com. (End 04/18) | 55.0 | 0.0 | $172,769 | $0 | $28,449 | Yes (X) | ||||
| Ria Williams | ||||||||||
| Controller | 55.0 | 0.0 | $172,059 | $0 | $42,500 | Yes (X) | ||||
| Subhendu Rath | ||||||||||
| Sr Dir, IT Enterprise Systems | 55.0 | 0.0 | $164,799 | $0 | $28,697 | Yes (X) | ||||
| Vanessa Hewitt | ||||||||||
| Sr Dir, Internal Audit | 55.0 | 0.0 | $158,438 | $0 | $30,560 | Yes (X) | ||||
| Kimberly Sabelko | ||||||||||
| Sr Dir, Scientific Strategy | 55.0 | 0.0 | $154,755 | $0 | $30,281 | Yes (X) | ||||
| Dr Judith Salerno | ||||||||||
| Former President & CEO | 0.0 | 0.0 | $271,623 | $0 | $0 | Yes (X) | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $3,208,123 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $403,527 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 49 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | Yes (true) | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt | Address Line1ContractorAddress/ForeignAddress/AddressLine1Txt | CityContractorAddress/ForeignAddress/CityNm | Province Or StateContractorAddress/ForeignAddress/ProvinceOrStateNm | CountryContractorAddress/ForeignAddress/CountryCd | Foreign PostalContractorAddress/ForeignAddress/ForeignPostalCd |
|---|---|---|---|---|---|---|---|---|---|---|
| Event 360 | ||||||||||
| 205 N Michigan Ave | CHICAGO | IL | 60601 | Event Management | $6,169,963 | |||||
| Stephen Thomas Ltd | ||||||||||
| Direct Marketing SS | $1,236,588 | 184 FRONT STREET EAST SUITE 501 | TORONTO | ONTARIO | CA | M5A 4N3 | ||||
| The Advertising Council Inc | ||||||||||
| 815 Second Avenue 9th floor | NEW YORK | NY | 10017 | Marketing | $649,147 | |||||
| Blackbaud Inc | ||||||||||
| PO Box 930256 | ATLANTA | GA | 311930256 | Donation Software Ss | $583,144 | |||||
| Laurel Strategies Inc | ||||||||||
| 4A Oxford Street | CHEVY CHASE | MD | 20815 | Consulting | $520,000 | |||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 19 | CntrctRcvdGreaterThan100KCnt |
| Federated Campaigns | $359,104 | FederatedCampaignsAmt |
| Fundraising | $16,005,958 | FundraisingAmt |
| All Other Contributions | $35,076,670 | AllOtherContributionsAmt |
| Noncash Contributions | $226,197 | NoncashContributionsAmt |
| Total Contributions | $51,441,732 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | Affiliate Research funds | Desc |
| Business | 900099 | BusinessCd |
| Total Revenue Column | $14,437,717 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $14,437,717 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $0 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $14,437,717 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $5,589,970 | TotalRevenueColumnAmt |
| Exclusion | $5,589,970 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $77,303 | TotalRevenueColumnAmt |
| Exclusion | $77,303 | ExclusionAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $36,121,988 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $27,472,877 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $8,649,111 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $8,649,111 | TotalRevenueColumnAmt |
| Exclusion | $8,649,111 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $723,932 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $16,005,958 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $5,693,721 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$4,969,789 | TotalRevenueColumnAmt |
| Exclusion | -$4,969,789 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gaming Gross Income | $0 | GamingGrossIncomeAmt |
| Gaming Direct Expenses | $0 | GamingDirectExpensesAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Exclusion | $0 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Sales Of Inventory | $16,300 | GrossSalesOfInventoryAmt |
| Cost Of Goods Sold | $78,217 | CostOfGoodsSoldAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$61,917 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | -$61,917 | RelatedOrExemptFuncIncomeAmt |
Other Revenue Misc OtherRevenueMiscGrp (2 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt | Unrelated Business RevenueUnrelatedBusinessRevenueAmt | ExclusionExclusionAmt |
|---|---|---|---|---|---|
| SHARED SERVICES INTERCOMPANY | 900099 | $1,449,319 | $1,449,319 | $0 | $0 |
| Other Income | 900099 | $124,523 | $0 | $6,100 | $118,423 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $1,573,842 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $76,737,969 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $15,825,119 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $6,100 | UnrelatedBusinessRevenueAmt |
| Exclusion | $9,465,018 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part IX | Yes (X) | InfoInScheduleOPartIXInd |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $26,648,984 | TotalAmt |
| Program Services | $26,648,984 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,346,806 | TotalAmt |
| Program Services | $2,346,806 | ProgramServicesAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,385,305 | TotalAmt |
| Program Services | $1,518,488 | ProgramServicesAmt |
| Management And General | $524,165 | ManagementAndGeneralAmt |
| Fundraising | $342,652 | FundraisingAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $0 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $15,494,732 | TotalAmt |
| Program Services | $9,844,534 | ProgramServicesAmt |
| Management And General | $3,409,690 | ManagementAndGeneralAmt |
| Fundraising | $2,240,508 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $697,170 | TotalAmt |
| Program Services | $450,252 | ProgramServicesAmt |
| Management And General | $143,152 | ManagementAndGeneralAmt |
| Fundraising | $103,766 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,790,058 | TotalAmt |
| Program Services | $1,117,213 | ProgramServicesAmt |
| Management And General | $415,564 | ManagementAndGeneralAmt |
| Fundraising | $257,281 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,075,363 | TotalAmt |
| Program Services | $679,564 | ProgramServicesAmt |
| Management And General | $243,794 | ManagementAndGeneralAmt |
| Fundraising | $152,005 | FundraisingAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $0 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $152,020 | TotalAmt |
| Program Services | $71,797 | ProgramServicesAmt |
| Management And General | $24,793 | ManagementAndGeneralAmt |
| Fundraising | $55,430 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $451,550 | TotalAmt |
| Program Services | $265,925 | ProgramServicesAmt |
| Management And General | $93,057 | ManagementAndGeneralAmt |
| Fundraising | $92,568 | FundraisingAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $210,678 | TotalAmt |
| Program Services | $210,678 | ProgramServicesAmt |
| Management And General | $0 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,118,493 | TotalAmt |
| Fundraising | $1,118,493 | FundraisingAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $69,358 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $69,358 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $0 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,954,534 | TotalAmt |
| Program Services | $1,277,995 | ProgramServicesAmt |
| Management And General | $101,529 | ManagementAndGeneralAmt |
| Fundraising | $575,010 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $9,016,836 | TotalAmt |
| Program Services | $5,380,940 | ProgramServicesAmt |
| Management And General | $104,276 | ManagementAndGeneralAmt |
| Fundraising | $3,531,620 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,638,065 | TotalAmt |
| Program Services | $1,249,384 | ProgramServicesAmt |
| Management And General | $160,872 | ManagementAndGeneralAmt |
| Fundraising | $227,809 | FundraisingAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $0 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $965,029 | TotalAmt |
| Program Services | $606,865 | ProgramServicesAmt |
| Management And General | $177,043 | ManagementAndGeneralAmt |
| Fundraising | $181,121 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,335,480 | TotalAmt |
| Program Services | $775,872 | ProgramServicesAmt |
| Management And General | $470,989 | ManagementAndGeneralAmt |
| Fundraising | $88,619 | FundraisingAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $0 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $262,622 | TotalAmt |
| Program Services | $201,420 | ProgramServicesAmt |
| Management And General | $61,202 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $0 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $0 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $587,266 | TotalAmt |
| Program Services | $275,331 | ProgramServicesAmt |
| Management And General | $246,241 | ManagementAndGeneralAmt |
| Fundraising | $65,694 | FundraisingAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $364,269 | TotalAmt |
| Program Services | $214,524 | ProgramServicesAmt |
| Management And General | $75,070 | ManagementAndGeneralAmt |
| Fundraising | $74,675 | FundraisingAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| Consult & Prof. Svcs | $10,117,705 | $8,215,278 | $446,132 | $1,456,295 |
| Equip Rental & Maint | $1,535,239 | $863,996 | $285,647 | $385,596 |
| Event Production | $1,472,174 | $870,165 | $371,078 | $230,931 |
| Bank fees | $919,608 | $381,253 | $64,922 | $473,433 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $667,096 | TotalAmt |
| Program Services | $259,891 | ProgramServicesAmt |
| Management And General | $242,722 | ManagementAndGeneralAmt |
| Fundraising | $164,483 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $83,276,440 | TotalAmt |
| Program Services | $63,727,155 | ProgramServicesAmt |
| Management And General | $7,731,296 | ManagementAndGeneralAmt |
| Fundraising | $11,817,989 | FundraisingAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Joint Costs | Yes (X) | JointCostsInd |
Total Joint Costs TotalJointCostsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $24,611,074 | TotalAmt |
| Program Services | $10,238,777 | ProgramServicesAmt |
| Management And General | $1,438,841 | ManagementAndGeneralAmt |
| Fundraising | $12,933,456 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $31,823,756 | BOYAmt |
| EOY | $31,040,869 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $20,419,320 | BOYAmt |
| EOY | $15,710,504 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,718,830 | BOYAmt |
| EOY | $2,934,675 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $102,613 | BOYAmt |
| EOY | $209,655 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,176,543 | BOYAmt |
| EOY | $1,215,980 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $9,239,331 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $8,071,129 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,639,690 | BOYAmt |
| EOY | $1,168,202 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $97,151,712 | BOYAmt |
| EOY | $101,757,276 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $64,468,904 | BOYAmt |
| EOY | $47,753,580 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $20,773 | BOYAmt |
| EOY | $20,773 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $220,522,141 | BOYAmt |
| EOY | $201,811,514 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $8,991,250 | BOYAmt |
| EOY | $6,873,683 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $82,800,353 | BOYAmt |
| EOY | $70,283,876 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $346,135 | BOYAmt |
| EOY | $247,500 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $92,137,738 | BOYAmt |
| EOY | $77,405,059 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $83,312,668 | BOYAmt |
| EOY | $86,358,517 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $44,746,735 | BOYAmt |
| EOY | $37,722,938 | EOYAmt |
Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $325,000 | BOYAmt |
| EOY | $325,000 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $128,384,403 | BOYAmt |
| EOY | $124,406,455 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $220,522,141 | BOYAmt |
| EOY | $201,811,514 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | -$6,538,471 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$228,854 | NetUnrlzdGainsLossesInvstAmt |
| Donated Services And Use Fclts | -$244,500 | DonatedServicesAndUseFcltsAmt |
| Investment Expense | $0 | InvestmentExpenseAmt |
| Prior Period Adjustments | $0 | PriorPeriodAdjustmentsAmt |
| Other Changes In Net Assets | $3,033,877 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | false | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $91,606,572 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $77,337,857 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $105,234,559 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $55,634,984 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $51,441,732 | CurrentTaxYearAmt |
| Total | $381,255,704 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $91,606,572 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $77,337,857 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $105,234,559 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $55,634,984 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $51,441,732 | CurrentTaxYearAmt |
| Total | $381,255,704 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $37,715,158 | SubstantialContributorsTotAmt |
| Public Support Total170 | $343,540,546 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $4,064,746 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $3,542,123 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $2,523,145 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $2,265,964 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $5,667,273 | CurrentTaxYearAmt |
| Total | $18,063,251 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $0 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $0 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $0 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $0 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $0 | CurrentTaxYearAmt |
| Total | $0 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $436,740 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $153,632 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $336,857 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $51,821 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $124,523 | CurrentTaxYearAmt |
| Total | $1,103,573 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $400,422,528 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $103,084,467 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.85794 | PublicSupportCY170Pct |
| Public Support PY170 | 0.86153 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Belongs Afflt Grp | Yes (X) | OrganizationBelongsAffltGrpInd |
Total Grassroots Lobbying TotalGrassrootsLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $10,245 | FilingOrganizationsTotalAmt |
| Affiliated Group Total | $19,478 | AffiliatedGroupTotalAmt |
Total Direct Lobbying TotalDirectLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $200,433 | FilingOrganizationsTotalAmt |
| Affiliated Group Total | $234,047 | AffiliatedGroupTotalAmt |
Total Lobbying Expend TotalLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $210,678 | FilingOrganizationsTotalAmt |
| Affiliated Group Total | $253,525 | AffiliatedGroupTotalAmt |
Other Exempt Purpose Expend OtherExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $75,334,466 | FilingOrganizationsTotalAmt |
| Affiliated Group Total | $153,056,366 | AffiliatedGroupTotalAmt |
Total Exempt Purpose Expend TotalExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $75,545,144 | FilingOrganizationsTotalAmt |
| Affiliated Group Total | $153,309,891 | AffiliatedGroupTotalAmt |
Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $1,000,000 | FilingOrganizationsTotalAmt |
| Affiliated Group Total | $1,000,000 | AffiliatedGroupTotalAmt |
Grassroots Nontaxable GrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $250,000 | FilingOrganizationsTotalAmt |
| Affiliated Group Total | $250,000 | AffiliatedGroupTotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tot Lbbyng Grassroot Mns Non Tx | TotLbbyngGrassrootMnsNonTxGrp | |
| Tot Lbby Expend Mns Lbbyng Non Tx | TotLbbyExpendMnsLbbyngNonTxGrp |
Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $1,000,000 | CurrentYearMinus3Amt |
| Current Year Minus2 | $1,000,000 | CurrentYearMinus2Amt |
| Current Year Minus1 | $1,000,000 | CurrentYearMinus1Amt |
| Current Year | $1,000,000 | CurrentYearAmt |
| Total | $4,000,000 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Lobbying Ceiling | $6,000,000 | LobbyingCeilingAmt |
Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $91,934 | CurrentYearMinus3Amt |
| Current Year Minus2 | $218,796 | CurrentYearMinus2Amt |
| Current Year Minus1 | $274,215 | CurrentYearMinus1Amt |
| Current Year | $253,525 | CurrentYearAmt |
| Total | $838,470 | TotalAmt |
Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $250,000 | CurrentYearMinus3Amt |
| Current Year Minus2 | $250,000 | CurrentYearMinus2Amt |
| Current Year Minus1 | $250,000 | CurrentYearMinus1Amt |
| Current Year | $250,000 | CurrentYearAmt |
| Total | $1,000,000 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grassroots Ceiling | $1,500,000 | GrassrootsCeilingAmt |
Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $52,478 | CurrentYearMinus3Amt |
| Current Year Minus2 | $66,033 | CurrentYearMinus2Amt |
| Current Year Minus1 | $19,341 | CurrentYearMinus1Amt |
| Current Year | $19,478 | CurrentYearAmt |
| Total | $157,330 | TotalAmt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Lobbying Expenses | FormAndLineReferenceDesc |
| Explanation | SCHEDULE C, PART II-A PUBLIC POLICY INITIATIVES HAVE THE POTENTIAL TO IMPACT PEOPLE TOUCHED BY BREAST CANCER. RECOGNIZING THE POWER OF ADVOCACY TO ACCOMPLISH ITS MISSION, KOMEN SUPPORTS LIMITED LOBBYING ACTIVITIES TO ACHIEVE EVIDENCE-BASED POLICY AND LEGISLATIVE SOLUTIONS DESIGNED TO END BREAST CANCER FOREVER. | ExplanationTxt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Art Public Exhibition Amounts | ArtPublicExhibitionAmountsGrp | |
| Held Works Art | HeldWorksArtGrp |
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $1,377,855 | BeginningYearBalanceAmt |
| Contributions | $0 | ContributionsAmt |
| Investment Earnings Or Losses | $10,034 | InvestmentEarningsOrLossesAmt |
| Grants Or Scholarships | $0 | GrantsOrScholarshipsAmt |
| Other Expenditures | $25,799 | OtherExpendituresAmt |
| Administrative Expenses | $0 | AdministrativeExpensesAmt |
| End Year Balance | $1,362,090 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $1,376,069 | BeginningYearBalanceAmt |
| Investment Earnings Or Losses | $1,786 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $0 | OtherExpendituresAmt |
| End Year Balance | $1,377,855 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $1,346,721 | BeginningYearBalanceAmt |
| Investment Earnings Or Losses | $29,808 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $460 | OtherExpendituresAmt |
| End Year Balance | $1,376,069 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $1,346,267 | BeginningYearBalanceAmt |
| Investment Earnings Or Losses | $4,717 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $4,263 | OtherExpendituresAmt |
| End Year Balance | $1,346,721 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $1,325,000 | BeginningYearBalanceAmt |
| Contributions | $0 | ContributionsAmt |
| Investment Earnings Or Losses | $23,736 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $2,469 | OtherExpendituresAmt |
| End Year Balance | $1,346,267 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.73000 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 0.24000 | PrmnntEndowmentBalanceEOYPct |
| Term Endowment Balance EOY | 0.03000 | TermEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | false | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | false | EndowmentsHeldRelatedOrgInd |
Land LandGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Book Value | $0 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Buildings | BuildingsGrp |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $610,067 | OtherCostOrOtherBasisAmt |
| Depreciation | $225,951 | DepreciationAmt |
| Book Value | $384,116 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $2,283,342 | OtherCostOrOtherBasisAmt |
| Depreciation | $2,099,946 | DepreciationAmt |
| Book Value | $183,396 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $6,345,922 | OtherCostOrOtherBasisAmt |
| Depreciation | $5,745,232 | DepreciationAmt |
| Book Value | $600,690 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $1,168,202 | TotalBookValueLandBuildingsAmt |
| Financial Derivatives | FinancialDerivativesGrp | |
| Closely Held Equity Interests | CloselyHeldEquityInterestsGrp |
Other Securities OtherSecuritiesGrp (2 entries)
| DescDesc | Book ValueBookValueAmt | Method ValuationMethodValuationCd |
|---|---|---|
| Long/short equity fund | $1,165,580 | F |
| Private equity fund | $46,588,000 | F |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Securities | $47,753,580 | TotalBookValueSecuritiesAmt |
| Federal Income Tax Liability | $0 | FederalIncomeTaxLiabilityAmt |
| Total Liability | $0 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| INTENDED USE OF ENDOWMENT FUNDS | SCHEDULE D, PART V, LINE 4 KOMEN HAS THREE PERMANENT ENDOWMENTS: GOODMAN-BRINKER, FIRNBERG, AND A GENERAL ENDOWMENT. THE GOODMAN-BRINKER ENDOWMENT IS FOR BREAST CANCER RESEARCH FELLOWSHIPS, THE FIRNBERG ENDOWMENT IS FOR BREAST CANCER EDUCATIONAL PROGRAMS AND RESEARCH AWARDS, AND THE GENERAL ENDOWMENT'S EARNINGS ARE RESTRICTED FOR ORGANIZATIONAL MISSION ACTIVITIES. |
| FIN 48 (ASC740) FINANCIAL STATEMENT DISCLOSURE | SCHEDULE D, PART X, LINE 2 THE ORGANIZATION IS SUBJECT TO A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. THERE WERE NO UNCERTAIN TAX POSITIONS RECORDED IN THE CONSOLIDATED FINANCIAL STATEMENTS AT MARCH 31, 2018 OR MARCH 31, 2017. |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (18 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| Central America and the Caribbean | 0 | 2 | Grantmaking | Education | $68,416 |
| Central America and the Caribbean | 0 | 1 | Grantmaking | Screening | $45,000 |
| East Asia and the Pacific | 0 | 2 | Grantmaking | Research | $269,871 |
| Europe (Including Iceland and Greenland) | 0 | 9 | Grantmaking | Research | $1,054,471 |
| Middle East and North Africa | 0 | 3 | Grantmaking | Education | $21,841 |
| North America | 0 | 5 | Grantmaking | Research | $672,834 |
| North America | 0 | 2 | Grantmaking | Screening | $61,239 |
| South America | 0 | 1 | Grantmaking | Education | $53,500 |
| South America | 0 | 1 | Grantmaking | Screening | $55,000 |
| South America | 0 | 1 | Grantmaking | Treatment | $34,880 |
| Sub-Saharan Africa | 0 | 1 | Grantmaking | Education | $9,754 |
| Europe (Including Iceland and Greenland) | 0 | 4 | Program Services | Program Support | $16,677 |
| North America | 0 | 7 | Program Services | Program Support | $69,529 |
| North America | 0 | 1 | Program Services | Direct Mail Processing | $9,080,694 |
| North America | 0 | 2 | Program Services | Marketing Support | $192,216 |
| North America | 0 | 1 | Program Services | Software Maintenance | $4,577 |
| South America | 0 | 2 | Program Services | Program Support | $43,405 |
| Sub-Saharan Africa | 0 | 3 | Program Services | Program Support | $23,581 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 45 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 3 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 48 | TotalEmployeeCnt |
| Subtotal Spent | $11,753,904 | SubtotalSpentAmt |
| Continuation Spent | $23,581 | ContinuationSpentAmt |
| Total Spent | $11,777,485 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (27 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt |
|---|---|---|---|
| North America | Screening Education Education Research Education Education Research Research Screening Research Research Screening Screening Research Research Research Treatment Research Education Research Research Education Research Education Research Research Research Research EDUCATION, TREATMENT RESEARCH RESEARCH, SCREENING, EDUCATION TREATMENT EDUCATION RESEARCH SCREENING, TREATMENT RESEARCH RESEARCH EDUCATION, TREATMENT RESEARCH SCREENING, TREATMENT RESEARCH RESEARCH EDUCATION, TREATMENT EDUCATION EDUCATION EDUCATION, TREATMENT RESEARCH RESEARCH RESEARCH RESEARCH RESEARCH RESEARCH EDUCATION, SCREENING, TREATMENT RESEARCH RESEARCH EDUCATION RESEARCH TREATMENT EDUCATION RESEARCH EDUCATION, RESEARCH RESEARCH RESEARCH EDUCATION RESEARCH RESEARCH RESEARCH RESEARCH RESEARCH RESEARCH RESEARCH TREATMENT RESEARCH RESEARCH EDUCATION, RESEARCH EDUCATION RESEARCH EDUCATION, RESEARCH EDUCATION EDUCATION RESEARCH RESEARCH RESEARCH RESEARCH RESEARCH RESEARCH EDUCATION, RESEARCH EDUCATION EDUCATION, SCREENING R | $59,241 | Wire Transfe |
| Central America and the Caribbean | Screening | $28,416 | Wire Transfe |
| Middle East and North Africa | Research | $10,000 | Wire Transfe |
| North America | Treatment | $50,000 | Wire Transfe |
| South America | Education | $53,500 | Wire Transfe |
| Sub-Saharan Africa | Research | $9,754 | Wire Transfe |
| Europe (including Iceland and Greenland) | Screening | $35,640 | Wire Transfe |
| Europe (including Iceland and Greenland) | Education | $35,000 | Wire Transfe |
| South America | Research | $55,000 | Wire Transfe |
| Europe (including Iceland and Greenland) | Research | $30,000 | Wire Transfe |
| Europe (including Iceland and Greenland) | Education | $120,000 | Wire Transfe |
| Central America and the Caribbean | Research | $45,000 | Wire Transfe |
| East Asia and the Pacific | Research | $149,871 | Wire Transfe |
| Europe (including Iceland and Greenland) | Research | $148,128 | Wire Transfe |
| Europe (including Iceland and Greenland) | Treatment | $60,000 | Wire Transfe |
| South America | Education | $34,880 | Wire Transfe |
| Europe (including Iceland and Greenland) | Education | $190,703 | Wire Transfe |
| Middle East and North Africa | Education | $6,500 | Wire Transfe |
| North America | Research | $190,000 | Wire Transfe |
| Europe (including Iceland and Greenland) | Research | $135,000 | Wire Transfe |
| Central America and the Caribbean | Research | $40,000 | Wire Transfe |
| North America | Research | $149,320 | Wire Transfe |
| Middle East and North Africa | Research | $5,341 | Wire Transfe |
| North America | Research | $55,121 | Wire Transfe |
| East Asia and the Pacific | Research | $120,000 | Wire Transfe |
| North America | Research | $228,394 | Wire Transfe |
| Europe (including Iceland and Greenland) | Education, Screening Treatment | $300,000 | Wire Transfe |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 28 | Total501c3OrgCnt |
| Transfer To Foreign Corp | false | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | Yes (true) | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | false | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PROCEDURES FOR MONITORING USE OF GRANT FUNDS OUTSIDE OF THE UNITED STATES | FormAndLineReferenceDesc |
| Explanation | SCHEDULE F, PART I, LINE 2 AS OUTLINED IN EACH GRANT AGREEMENT, ALL GRANTEES ARE REQUIRED TO SUBMIT, AT A MINIMUM, ONE FINANCIAL AND PROGRESS REPORT WITHIN EACH YEAR OF THE GRANT TERM, AND ANY CHANGE REQUESTS THEY MAY HAVE FOR THEIR PROJECTS. ALL PROGRESS REPORTS AND REQUESTS ARE REVIEWED BY QUALIFIED STAFF. SEE SCHEDULE I, PART IV FOR MORE DETAILS. | ExplanationTxt |
Schedule G IRS990ScheduleG
| Field | Value | IRS element (for citing) |
|---|---|---|
| Mail Solicitations | Yes (X) | MailSolicitationsInd |
| Email Solicitations | Yes (X) | EmailSolicitationsInd |
| Phone Solicitations | Yes (X) | PhoneSolicitationsInd |
| In Person Solicitations | Yes (X) | InPersonSolicitationsInd |
| Solicitation Of Non Govt Grants | Yes (X) | SolicitationOfNonGovtGrantsInd |
| Special Fundraising Events | Yes (X) | SpecialFundraisingEventsInd |
| Agrmt Prof Fundraising Acty | Yes (true) | AgrmtProfFundraisingActyInd |
Fundraiser Activity Info FundraiserActivityInfoGrp (6 entries)
| ActivityActivityTxt | Fundraiser Control Of FundsFundraiserControlOfFundsInd | Gross ReceiptsGrossReceiptsAmt | Retained By ContractorRetainedByContractorAmt | Net To OrganizationNetToOrganizationAmt | Address Line1ForeignAddress/AddressLine1Txt | CityForeignAddress/CityNm | Province Or StateForeignAddress/ProvinceOrStateNm | CountryForeignAddress/CountryCd | Foreign PostalForeignAddress/ForeignPostalCd | Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Event 360 | |||||||||||||
| Fundraising Consulting | false | $15,672,171 | $380,000 | $15,292,171 | |||||||||
| Stephen Thomas LTD | |||||||||||||
| Direct Marketing | false | $14,447,032 | $464,592 | $13,982,441 | 184 Front Street East Suite 501 | Toronto | Ontario | CA | M5A 4N3 | ||||
| Infinite Agency | |||||||||||||
| Marketing Consulting | false | $1,326,000 | $126,522 | $1,199,478 | PO Box 51706 | Lafayette | LA | 70505 | |||||
| Artsmarketing Svcs Inc | |||||||||||||
| Telemarketg | false | $111,220 | $63,412 | $47,808 | 260 King Street East Suite 500 | Toronto | Ontario | CA | M5A4L5 | ||||
| Merkle Inc | |||||||||||||
| Direct Marketing | false | $49,105 | 100 Jamison Court | Hagerstown | MD | 21740 | |||||||
| Bob Carter Companies | |||||||||||||
| Fundraising Consulting | false | $34,862 | 400 Madison Drive Suite 204 | Sarasota | FL | 34236 | |||||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Gross Receipts | $31,556,423 | TotalGrossReceiptsAmt |
| Total Retained By Contractors | $1,118,493 | TotalRetainedByContractorsAmt |
| Total Net To Organization | $30,521,898 | TotalNetToOrganizationAmt |
| Licensed States | AL | LicensedStatesCd |
| Licensed States | AK | LicensedStatesCd |
| Licensed States | AZ | LicensedStatesCd |
| Licensed States | AR | LicensedStatesCd |
| Licensed States | CA | LicensedStatesCd |
| Licensed States | CO | LicensedStatesCd |
| Licensed States | CT | LicensedStatesCd |
| Licensed States | DC | LicensedStatesCd |
| Licensed States | FL | LicensedStatesCd |
| Licensed States | GA | LicensedStatesCd |
| Licensed States | HI | LicensedStatesCd |
| Licensed States | ID | LicensedStatesCd |
| Licensed States | IL | LicensedStatesCd |
| Licensed States | IN | LicensedStatesCd |
| Licensed States | IA | LicensedStatesCd |
| Licensed States | KS | LicensedStatesCd |
| Licensed States | KY | LicensedStatesCd |
| Licensed States | LA | LicensedStatesCd |
| Licensed States | ME | LicensedStatesCd |
| Licensed States | MD | LicensedStatesCd |
| Licensed States | MA | LicensedStatesCd |
| Licensed States | MI | LicensedStatesCd |
| Licensed States | MN | LicensedStatesCd |
| Licensed States | MS | LicensedStatesCd |
| Licensed States | MO | LicensedStatesCd |
| Licensed States | MT | LicensedStatesCd |
| Licensed States | NE | LicensedStatesCd |
| Licensed States | NV | LicensedStatesCd |
| Licensed States | NH | LicensedStatesCd |
| Licensed States | NJ | LicensedStatesCd |
| Licensed States | NM | LicensedStatesCd |
| Licensed States | NY | LicensedStatesCd |
| Licensed States | NC | LicensedStatesCd |
| Licensed States | ND | LicensedStatesCd |
| Licensed States | OH | LicensedStatesCd |
| Licensed States | OK | LicensedStatesCd |
| Licensed States | OR | LicensedStatesCd |
| Licensed States | PA | LicensedStatesCd |
| Licensed States | RI | LicensedStatesCd |
| Licensed States | SC | LicensedStatesCd |
| Licensed States | SD | LicensedStatesCd |
| Licensed States | TN | LicensedStatesCd |
| Licensed States | TX | LicensedStatesCd |
| Licensed States | UT | LicensedStatesCd |
| Licensed States | VT | LicensedStatesCd |
| Licensed States | VA | LicensedStatesCd |
| Licensed States | WA | LicensedStatesCd |
| Licensed States | WV | LicensedStatesCd |
| Licensed States | WI | LicensedStatesCd |
| Licensed States | WY | LicensedStatesCd |
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | 3 Day | Event1Nm |
| Gross Receipts Event1 | $14,764,958 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $14,403,799 | CharitableContriEvent1Amt |
| Gross Revenue Event1 | $361,159 | GrossRevenueEvent1Amt |
| Cash Prizes Event1 | $0 | CashPrizesEvent1Amt |
| Non Cash Prizes Event1 | $31,735 | NonCashPrizesEvent1Amt |
| Rent Facility Costs Event1 | $950,464 | RentFacilityCostsEvent1Amt |
| Food And Beverage Event1 | $720,176 | FoodAndBeverageEvent1Amt |
| Other Direct Expenses Event1 | $3,503,257 | OtherDirectExpensesEvent1Amt |
| Event2 | DC Race | Event2Nm |
| Gross Receipts Event2 | $724,107 | GrossReceiptsEvent2Amt |
| Charitable Contri Event2 | $533,484 | CharitableContriEvent2Amt |
| Gross Revenue Event2 | $190,623 | GrossRevenueEvent2Amt |
| Cash Prizes Event2 | $0 | CashPrizesEvent2Amt |
| Rent Facility Costs Event2 | $57,402 | RentFacilityCostsEvent2Amt |
| Food And Beverage Event2 | $34,256 | FoodAndBeverageEvent2Amt |
| Other Direct Expenses Event2 | $125,503 | OtherDirectExpensesEvent2Amt |
| Other Events Total | 3 | OtherEventsTotalCnt |
| Gross Receipts Other Events | $1,240,825 | GrossReceiptsOtherEventsAmt |
| Charitable Contri Other Events | $1,068,675 | CharitableContriOtherEventsAmt |
| Gross Revenue Other Events | $172,150 | GrossRevenueOtherEventsAmt |
| Cash Prizes Other Events | $0 | CashPrizesOtherEventsAmt |
| Non Cash Prizes Other Events | $1,787 | NonCashPrizesOtherEventsAmt |
| Rent Fclty Costs Other Events | $86,612 | RentFcltyCostsOtherEventsAmt |
| Food And Beverage Other Events | $112,000 | FoodAndBeverageOtherEventsAmt |
| Entertainment Other Events | $47,090 | EntertainmentOtherEventsAmt |
| Oth Direct Expnss Other Events | $23,439 | OthDirectExpnssOtherEventsAmt |
| Gross Receipts Total | $16,729,890 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $16,005,958 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $723,932 | GrossRevenueTotalEventsAmt |
| Cash Prizes Total Events | $0 | CashPrizesTotalEventsAmt |
| Non Cash Prizes Total Events | $33,522 | NonCashPrizesTotalEventsAmt |
| Rent Fclty Costs Total Events | $1,094,478 | RentFcltyCostsTotalEventsAmt |
| Food And Beverage Total Events | $866,432 | FoodAndBeverageTotalEventsAmt |
| Entertainment Total Events | $47,090 | EntertainmentTotalEventsAmt |
| Oth Direct Expnss Total Events | $3,652,199 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $5,693,721 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | -$4,969,789 | NetIncomeSummaryAmt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | NET INCOME SUMMARY | FormAndLineReferenceDesc |
| Explanation | SCHEDULE G PART II Gross receipts are reduced by the amount of contributions, per IRS instructions. The contributions for fiscal year 2018 were $16,005,958. | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (142 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|
| African Women's Cancer Awareness Assoc | |||||||
| 8955 Edmonston Road | Greenbelt | MD | 20770 | 731704355 | 501(C)(3) | $57,004 | Research |
| Albany Medical College | |||||||
| Attn Frances Albert | Albany | NY | 12208 | 141338310 | 501(C)(3) | $150,000 | Education |
| American Association for Cancer Research | |||||||
| 615 Chestnut Street 17th Fl | Philadelphia | PA | 191064404 | 236251649 | 501(C)(3) | $328,000 | Research |
| American Association on Health & Disabil | |||||||
| 110 N Washington StreetSuite 328J | Rockville | MD | 20850 | 521884887 | 501(C)(3) | $44,165 | Education |
| American Jewish Joint | |||||||
| Attn Itai Shamir | New York | NY | 100174014 | 131656634 | 501(C)(3) | $112,500 | Research |
| American Society of Clinical Oncology | |||||||
| Conquer Cancer Foundation | Alexandria | VA | 22314 | 136180880 | 501(C)(3) | $100,000 | Research |
| Arlington Free Clinic | |||||||
| 2921 11th Street South | Arlington | VA | 22204 | 541671883 | 501(C)(3) | $59,959 | Research |
| Baylor College Medicine | |||||||
| Grants - Accounts Receivable | Houston | TX | 770303411 | 741613878 | 501(C)(3) | $951,217 | Education |
| Beth Israel Deaconess Medical Center | |||||||
| Research Finance Office BR109 | Boston | MA | 02215 | 042103881 | 501(C)(3) | $162,000 | Research |
| Boat People SOS | |||||||
| 6066 Leesburg Pike 100 | Falls Church | VA | 220412220 | 541563619 | 501(C)(3) | $65,327 | Treatment |
| Boston University | |||||||
| 580 Harrison Avenue 3-W | Boston | MA | 02118 | 042103547 | 501(C)(3) | $108,000 | Research |
| Breast Care for Washington | |||||||
| 4 Atlantic St SW | Washington | DC | 20032 | 455574713 | 501(C)(3) | $60,000 | Research |
| Brigham & Women's Hospital | |||||||
| PO Box 3149 | Boston | MA | 022413149 | 042312909 | 501(C)(3) | $323,929 | Research |
| Broad Institute Inc | |||||||
| 415 Main Street | Cambridge | MA | 02142 | 263428781 | 501(C)(3) | $122,996 | Research |
| Cancer Care | |||||||
| 275 Seventh Avenue | New York | NY | 10001 | 131825919 | 501(C)(3) | $1,439,879 | Education |
| Cancer Resource Centers of Mendocino Cty | |||||||
| 45040 Calpella Street | Mendocino | CA | 95460 | 680357416 | 501(C)(3) | $13,108 | Research |
| Capital Breast Care Center | |||||||
| 3970 Reservoir Road NW | Washington | DC | 200571468 | 530196603 | 501(C)(3) | $50,000 | Research |
| CASA of Maryland Inc | |||||||
| Attn Jennifer Freedman | Hyattsville | MD | 20783 | 521372972 | 501(C)(3) | $35,000 | Research |
| Case Western Reserve University | |||||||
| Controllers Office | Cleveland | OH | 441067006 | 341018992 | 501(C)(3) | $294,311 | Education |
| Children's Hospital Boston | |||||||
| Research Finance | Boston | MA | 022414413 | 042774441 | 501(C)(3) | $108,000 | Research |
| Cold Spring Harbor Laboratory | |||||||
| Attn Walter Goldschmidts | Cold Spring Harbor | NY | 11724 | 112013303 | 501(C)(3) | $168,000 | Education, Research |
| Columbia University Medical Center | |||||||
| 722 West 168th Street 4th Floor | New York | NY | 10032 | 135598093 | 501(C)(3) | $646,000 | Education |
| Cornell University | |||||||
| Attn Ilene Lambiase | Ithaca | NY | 14850 | 150532082 | 501(C)(3) | $48,000 | Screening |
| Dana Farber Cancer Institute | |||||||
| 44 Binney Street Mail Stop 439C | Boston | MA | 02115 | 042263040 | 501(C)(3) | $1,994,658 | Education, Screening, Treatment |
| Doctors Community Hospital | |||||||
| 8118 Good Luck Road | Lanham | MD | 207063502 | 521638026 | 501(C)(3) | $75,000 | Research |
| Dr Susan Love Research Foundation | |||||||
| 2811 Wilshire Blvd | Santa Monica | CA | 90403 | 770009065 | 501(C)(3) | $25,000 | Research |
| Duke University Medical Center | |||||||
| PO Box 602651 | Charlotte | NC | 282602651 | 560532129 | 501(C)(3) | $536,052 | Research |
| Eastern Michigan University | |||||||
| Attn Susan Shipley | Ypsilanti | MI | 48197 | 382953297 | 501(C)(3) | $225,074 | Research |
| Emory University Winship Cancer Inst | |||||||
| PO Box 935084 | Atlanta | GA | 311935084 | 580566256 | 501(C)(3) | $150,000 | Research |
| Ethiopian Community Development Council | |||||||
| Attn Azeb Tadesse | Arlington | VA | 22204 | 521308986 | 501(C)(3) | $50,000 | Education |
| Facing Our Risk of Cancer Empowered | |||||||
| 16057 Tampa Palms Blvd W 373 | Tampa | FL | 33647 | 650927702 | 501(C)(3) | $6,000 | Education, Research |
| Fox Chase Cancer Center | |||||||
| 333 Cottman Avenue | Philadelphia | PA | 19111 | 232003072 | 501(C)(3) | $150,000 | Education |
| Fred Hutchinson Cancer Research Center | |||||||
| PO Box 19024 Mailstop J6-330 | Seattle | WA | 981091024 | 563744111 | 501(C)(3) | $334,998 | Education, Screening |
| George Mason University | |||||||
| 4400 University Drive MSN 4C6 | Fairfax | VA | 22030 | 540836354 | 501(C)(3) | $29,686 | Research |
| George Washington University | |||||||
| Grants and Contracts Accounting Svc | Ashburn | VA | 20147 | 530196584 | 501(C)(3) | $44,653 | Education, Screening, Treatment |
| Georgetown U | |||||||
| Attn Jemas Reisert | Washington | DC | 200571164 | 530196603 | 501(C)(3) | $243,000 | Research |
| Georgia Tech Research Corporation | |||||||
| 505 Tenth Street NW | Atlanta | GA | 30318 | 580603146 | 501(C)(3) | $150,000 | Research |
| Global Biological Standards Institute | |||||||
| 1020 19th Street NW Suite 550 | Washington | DC | 20036 | 611705421 | 501(C)(3) | $8,000 | Research |
| H Lee Moffitt Cancer Center | |||||||
| 12902 Magnolia Drive | Tampa | FL | 33612 | 593238636 | 501(C)(3) | $348,000 | Education |
| Harvard Medical School | |||||||
| Holyoke Center Room 600 | Cambridge | MA | 02138 | 042103580 | 501(C)(3) | $97,000 | Research |
| Harvard University | |||||||
| 25 Shattuck Street Sponsored Prgms | Boston | MA | 02115 | 042103580 | 501(C)(3) | $120,000 | Research |
| Henry Ford Health System | |||||||
| One Ford Place 5E | Detroit | MI | 48202 | 381357020 | 501(C)(3) | $200,000 | Research |
| Howard University | |||||||
| 2041 Georgia Avenue NW | Washington | DC | 20060 | 530204707 | 501(C)(3) | $49,994 | Education |
| Hudson-Alpha Institute for Biotechnology | |||||||
| 601 Genome Way | Huntsville | AL | 35801 | 432059317 | 501(C)(3) | $28,125 | Education |
| Indiana University (Indianapolis) | |||||||
| PO Box 66057 | Indianapolis | IN | 46266 | 356001673 | 501(C)(3) | $1,477,684 | Treatment |
| Johns Hopkins University | |||||||
| 1101 East 33rd Street Eastern C220 | Baltimore | MD | 21218 | 520595110 | 501(C)(3) | $2,391,260 | Research |
| Korean Community Svc Ctr of Greater WA | |||||||
| Attn Jai Hoon Jung | Annandale | VA | 22003 | 386005984 | 501(C)(3) | $10,000 | Education |
| Leland Stanford Jr University | |||||||
| PO Box 44253 | San Francisco | CA | 941444253 | 941156365 | 501(C)(3) | $546,989 | Screening, Treatment |
| Living Beyond Breast Cancer | |||||||
| Attn Jean Sachs CEO | Haverford | PA | 19041 | 530196932 | 501(C)(3) | $20,000 | Education, Screening |
| Maasai Wildernes Conservation Fund | |||||||
| PO Box 1413 | Santa Barbara | CA | 93102 | 541943145 | 501(C)(3) | $60,000 | Research |
| Mary's Ctr for Maternal&Child Care Inc | |||||||
| 2333 Ontario Road NW | Washington | DC | 20009 | 521594116 | 501(C)(3) | $125,291 | Education |
| Massachusetts General Hospital | |||||||
| PO Box 414876 | Boston | MA | 022414876 | 042697983 | 501(C)(3) | $528,910 | Education |
| Mayo Clinic Jacksonville | |||||||
| Griffin Building Room 170 | Jacksonville | FL | 32224 | 593337028 | 501(C)(3) | $100,000 | Research |
| Mayo Clinic Rochester | |||||||
| dba Mayo Clinic College of Medicine | Rochester | MN | 559034008 | 416011702 | 501(C)(3) | $200,000 | Education |
| Medical College of Wisconsin | |||||||
| 1234 Any Street | Anywhere | TX | 75244 | 390806261 | 501(C)(3) | $150,000 | Research |
| Medical Univeristy of South Carolina | |||||||
| 171 Ashley Avenue | Charleston | SC | 29425 | 576000722 | 501(C)(3) | $120,000 | Research |
| Memorial Sloan-Kettering Cancer Ctr | |||||||
| 633 3rd Avenue 28th Floor | New York | NY | 10017 | 131924236 | 501(C)(3) | $160,000 | Research |
| Metropolitan Chicago Breast Cancer | |||||||
| 1645 W Jackson Blvd Ste 450 | Chicago | IL | 606123244 | 262264895 | 501(C)(3) | $100,000 | Education, Screening, Treatment |
| MidMichigan Medical Center-Gratiot | |||||||
| 300 East Warwick Drive | Alma | MI | 48801 | 381437919 | 501(C)(3) | $13,889 | Research |
| Mobile Medical Care Inc | |||||||
| 9309 Old Georgetown Road | Bethesda | MD | 208141620 | 237022588 | 501(C)(3) | $29,416 | Screening |
| Mount Sinai School of Medicine | |||||||
| Sponsored Proj Actg | New York | NY | 100296574 | 136171197 | 501(C)(3) | $396,000 | Education |
| Neighborhood Health | |||||||
| 6677 Richmond Highway | Alexandria | VA | 22306 | 541849891 | 501(C)(3) | $139,917 | Research |
| New York University School of Med | |||||||
| General Accounting/Accounts Receiva | New York | NY | 10016 | 135562308 | 501(C)(3) | $120,000 | Education |
| North Carolina Central University | |||||||
| 1801 Fayetteville Street | Durham | NC | 27707 | 566000730 | 501(C)(3) | $135,000 | Research |
| Northwestern University - Chicago | |||||||
| 633 Clark | Evanston | IL | 60208 | 362167817 | 501(C)(3) | $448,219 | Treatment |
| Nueva Vida Inc | |||||||
| 2000 P Street NW Suite 300 | Washington | DC | 20036 | 541943145 | 501(C)(3) | $64,879 | Research |
| Obesity Society | |||||||
| 8757 Georgia Avenue | Silver Spring | MD | 20910 | 541438429 | 501(C)(3) | $8,000 | Research |
| Oregon Health & Science University | |||||||
| Sponsored Program Admin | Portland | OR | 97239 | 752668014 | 501(C)(3) | $909,855 | Research |
| Partners for Cancer Care and Prevention | |||||||
| 10 East Lee Street Unit 1901 | Baltimore | MD | 21202 | 451605551 | 501(C)(3) | $67,500 | Research |
| Patient Advocate Foundation | |||||||
| 421 Butler Farm Road | Hampton | VA | 23666 | 830292601 | 501(C)(3) | $25,000 | Research |
| Prevent Cancer Foundation | |||||||
| 1600 Duke Street | Alexandria | VA | 22209 | 521429544 | 501(C)(3) | $10,000 | Research |
| Primary Care Coalition-MontgomeryCty Inc | |||||||
| 8757 Georgia Avenue 10th Floor | Silver Spring | MD | 20910 | 521847976 | 501(C)(3) | $250,000 | Research |
| Prince William Hospital | |||||||
| 8700 Sudley Road | Manassas | VA | 20110 | 541307595 | 501(C)(3) | $93,057 | Research |
| Princeton University | |||||||
| 701 Carnegie Center | Princeton | NJ | 08540 | 210634501 | 501(C)(3) | $208,000 | Research |
| Program for Appropriate | |||||||
| PO Box 900922 | Seattle | WA | 98109 | 911157127 | 501(C)(3) | $45,646 | Research |
| Providence Portland Medical Center | |||||||
| 4805 NE Glisan St 5F40 | Portland | OR | 97213 | 930386906 | 501(C)(3) | $120,000 | Research |
| Purdue University | |||||||
| Sponsored Program Services | Chicago | IL | 606731235 | 356002041 | 501(C)(3) | $150,000 | Research |
| Quantum Leap HealthCare Collaborative | |||||||
| 3450 California Street | San Francisco | CA | 941181837 | 204284925 | 501(C)(3) | $10,000 | Research |
| Reagan Udall Foundation | |||||||
| Attn Georges Benjamin MD | Washington | DC | 20001 | 263727917 | 501(C)(3) | $10,000 | Research |
| Research Advocacy Network | |||||||
| 6505 West Park Boulevard | Plano | TX | 75093 | 566001393 | 501(C)(3) | $72,295 | Research |
| Rockefeller University | |||||||
| Attn Shawn Davis Ofc of Developme | New York | NY | 10065 | 131624158 | 501(C)(3) | $150,000 | Research |
| Roswell Park Alliance Foundation | |||||||
| Department of Immunology | Buffalo | NY | 14263 | 161391608 | 501(C)(3) | $158,690 | Research |
| Smith Farm Center for Healing & the Arts | |||||||
| 1632 U Street NW | Washington | DC | 20009 | 590624458 | 501(C)(3) | $50,000 | Research |
| St Joseph Medical Center | |||||||
| 2500 Bernville Road | Reading | PA | 196030316 | 530196617 | 501(C)(3) | $17,257 | Research |
| Stanford University | |||||||
| PO Box 44253 | San Francisco | CA | 941444253 | 941156365 | 501(C)(3) | $180,000 | Research |
| Stevens Institute of Technology | |||||||
| 1 Castle Point Terrace | Hoboken | NJ | 07030 | 221487354 | 501(C)(3) | $60,000 | Research |
| SUNY at Stony Brook | |||||||
| Attn Joann DeLucia-Conlon | Stony Brook | NY | 11794 | 146013200 | 501(C)(3) | $374,389 | Education, Research |
| Supporting Our Sisters International In | |||||||
| 2604 Pinebrook Ave C2 | Hyattsville | MD | 20785 | 472511778 | 501(C)(3) | $10,000 | Research |
| Temple University | |||||||
| Attn Jeanette West Pastelak | Philadelphia | PA | 19122 | 231365971 | 501(C)(3) | $60,000 | Research |
| The Ohio State University College | |||||||
| Attn Kathy Milem | Columbus | OH | 43205 | 316025986 | 501(C)(3) | $258,000 | Research |
| The Salk Institute | |||||||
| Attn Christine Marckese | La Jolla | CA | 920371002 | 952160097 | 501(C)(3) | $228,070 | Education, Research |
| The University of Chicago | |||||||
| Research Administration | Chicago | IL | 60637 | 362177139 | 501(C)(3) | $334,999 | Research |
| The Vanderbilt University | |||||||
| PMB 406310 | Nashville | TN | 372406310 | 620476822 | 501(C)(3) | $48,000 | Research |
| The Wistar Institute | |||||||
| 3601 Spruce Street | Philadelphia | PA | 191044265 | 236434390 | 501(C)(3) | $150,000 | Research |
| Trustees of Columbia Univ | |||||||
| Sponsored Projects Finance | New York | NY | 10027 | 135598093 | 501(C)(3) | $150,000 | Research |
| Trustees of Dartmouth College | |||||||
| Office of Sponsored Projects | Hanover | NH | 037551404 | 020222111 | 501(C)(3) | $120,000 | Research |
| Tufts University | |||||||
| 800 Washington Street | Boston | MA | 02111 | 042103634 | 501(C)(3) | $242,712 | Research |
| Tulane University Health Sciences Center | |||||||
| 800 E Commerce | Harahan | LA | 70023 | 720423889 | 501(C)(3) | $120,000 | Research |
| Univ of Colorado Health Sciences Cent | |||||||
| Attn George Johnston | Denver | CO | 802910238 | 846002597 | 501(C)(3) | $150,000 | Research |
| Univ of North Carolina at Chapel Hill | |||||||
| 104 Airport Drive Suite 2200 CB | Chapel Hill | NC | 275991350 | 566001393 | 501(C)(3) | $2,157,806 | Research |
| Univ of Texas MD Anderson Cancer Center | |||||||
| Grants Contracts | Houston | TX | 772104390 | 746001118 | 501(C)(3) | $774,111 | Research |
| University Miami School of Medicine | |||||||
| Attn Maria A Garcia | Atlanta | GA | 303845803 | 590624458 | 501(C)(3) | $120,000 | Research |
| University of Alabama at Birmingham | |||||||
| 1530 3rd Avenue South | Birmingham | AL | 352940111 | 636005396 | 501(C)(3) | $408,000 | Education, Screening, Treatment |
| University of California-San Francisco | |||||||
| 1600 Divisadero St Box 1710 | San Francisco | CA | 94115 | 946036493 | 501(C)(3) | $764,159 | Research |
| University of California-Berkeley | |||||||
| 2195 Hearst Avenue Room 130 | Berkeley | CA | 947201103 | 946002123 | 501(C)(3) | $243,000 | Research |
| University of California-Davis | |||||||
| Cashiers Office | West Sacramento | CA | 957989062 | 946036494 | 501(C)(3) | $59,983 | Research |
| University of California-Los Angeles | |||||||
| UCLA Remittance Center | Los Angeles | CA | 900246503 | 956006143 | 501(C)(3) | $390,000 | Research |
| University of California-San Diego | |||||||
| UCSD Cashiers Office | La Jolla | CA | 92093 | 956006144 | 501(C)(3) | $228,000 | Education, Treatment |
| University of Cincinnati | |||||||
| 51 Goodman Dr Univ Hall Suite 5 | Cincinnati | OH | 452210222 | 316000989 | 501(C)(3) | $120,000 | Screening |
| University of Colorado Denver | |||||||
| 13001 E 17th Place | Aurora | CO | 800452571 | 846002597 | 501(C)(3) | $75,975 | Research |
| University of Delaware | |||||||
| 30 Lovett Aenue | Newark | DE | 19716 | 516000279 | 501(C)(3) | $150,000 | Education |
| University of Illinois at Chicago | |||||||
| 809 S Marshfield Avenue MC551 | Chicago | IL | 606081264 | 376000511 | 501(C)(3) | $104,059 | EDUCATION |
| University of Illinois-Urbana-Champaign | |||||||
| Grants Contracts-Post Award | Springfield | IL | 627084610 | 376000511 | 501(C)(3) | $60,000 | SCREENING |
| University of Kansas Medical Center | |||||||
| ATTN TIM SISKEY KANSAS CITY KS 66 | Kansas City | KS | 66160 | 481108830 | 501(C)(3) | $583,275 | EDUCATION |
| University of Kentucky Research Fndn | |||||||
| Markey Cancer Center | Lexington | KY | 405260001 | 616033693 | 501(C)(3) | $75,948 | EDUCATION |
| University of Massachusetts Amherst | |||||||
| Goodell Bldg Room 405 | Amherst | MA | 010033210 | 043167352 | 501(C)(3) | $149,944 | EDUCATION |
| University of Miami School of Medicine | |||||||
| Center for Cancer Prevention and Ge | Miami | FL | 33136 | 590624458 | 501(C)(3) | $60,000 | RESEARCH |
| University of Michigan | |||||||
| Alexandra Thebaud | Ann Arbor | MI | 481091274 | 386006309 | 501(C)(3) | $255,000 | EDUCATION |
| University of Minnesota | |||||||
| McNamara Alumni Center | Minneapolis | MN | 554552070 | 416007513 | 501(C)(3) | $180,000 | RESEARCH |
| University of Pennsylvania | |||||||
| Office of Research Services | Philadelphia | PA | 191046205 | 231352685 | 501(C)(3) | $819,727 | EDUCATION |
| University of Pittsburgh | |||||||
| 350 Thackeray Hall | Pittsburgh | PA | 15260 | 250965591 | 501(C)(3) | $773,574 | EDUCATION |
| University of South CarolinaThe | |||||||
| 1600 Hampton Street Suite 404H | Columbia | SC | 29208 | 576001153 | 501(C)(3) | $135,000 | RESEARCH |
| University of Southern California | |||||||
| Attn Robert Osuna | Los Angeles | CA | 900898001 | 951642394 | 501(C)(3) | $818,086 | RESEARCH |
| University of Texas at Health Science Ce | |||||||
| Elizabeth Frantz | Houston | TX | 77030 | 741587488 | 501(C)(3) | $259,916 | EDUCATION, SCREENING |
| University of Utah | |||||||
| 201 South Presidents Circle Room | Salt Lake City | UT | 841129020 | 876000525 | 501(C)(3) | $296,000 | RESEARCH |
| University of Virginia at School of Medi | |||||||
| PO Box 400195 | Charlottesville | VA | 229044195 | 546001796 | 501(C)(3) | $150,000 | RESEARCH |
| University of Washington | |||||||
| Attn Tami Sadusky | Seattle | WA | 98105 | 916001537 | 501(C)(3) | $502,837 | EDUCATION |
| University of Wisconsin - Madison | |||||||
| Research Sponsored Programs | Madison | WI | 537151218 | 396006492 | 501(C)(3) | $179,383 | EDUCATION, SCREENING |
| UT HSC - San Antonio | |||||||
| Office of Sponsored Programs | San Antonio | TX | 772293900 | 741586031 | 501(C)(3) | $150,000 | RESEARCH |
| UT Southwestern Medical Center | |||||||
| UT Southwestern Grants Mgmt | Dallas | TX | 752841753 | 746000203 | 501(C)(3) | $210,000 | RESEARCH |
| UTMD Anderson Cancer Ctr | |||||||
| 1515 Holcombe Boulevard Unit 1644 | Houston | TX | 770304009 | 746001118 | 501(C)(3) | $364,479 | EDUCATION, TREATMENT |
| Vanderbilt University Medical Center | |||||||
| 1161 21st Avenue South | Nashville | TN | 372325545 | 620476822 | 501(C)(3) | $1,242,169 | EDUCATION, RESEARCH |
| Vermont Cancer Ctr UVM College of Med | |||||||
| Attn Jennifer Gagnon | Burlington | VT | 05405 | 030179440 | 501(C)(3) | $150,000 | RESEARCH |
| Vietnamese Resettlement Association Inc | |||||||
| Attn Kim O Cook | Falls Church | VA | 22044 | 541512549 | 501(C)(3) | $279,182 | RESEARCH |
| Virginia Commonwealth University | |||||||
| Attn Mark Roberts | Richmond | VA | 232843038 | 546001758 | 501(C)(3) | $25,204 | RESEARCH |
| Washington Univ at St Louis | |||||||
| 700 Rosedale Ave Campus Box 1034 | St Louis | MO | 63112 | 430653611 | 501(C)(3) | $1,059,427 | RESEARCH |
| Wayne State University | |||||||
| Sponsored Program Admin | Detroit | MI | 48201 | 366028429 | 501(C)(3) | $143,999 | EDUCATION |
| Weill Medical College of Cornell Univ | |||||||
| 1300 York Avenue | New York | NY | 10061 | 131623978 | 501(C)(3) | $60,000 | EDUCATION |
| Whitehead Inst for Biomedical Research | |||||||
| 9 Cambridge Center | Cambridge | MA | 021421479 | 061043412 | 501(C)(3) | $48,000 | EDUCATION |
| Whitman-Walker Clinic | |||||||
| 1701 14th Street NW | Washington | DC | 20009 | 521122122 | 501(C)(3) | $194,136 | RESEARCH |
| Yale University | |||||||
| 2 Whitney Avenue | New Haven | CT | 06510 | 060646973 | 501(C)(3) | $200,000 | RESEARCH |
| Young Survival Coalition | |||||||
| Lori Atkinson | New York | NY | 10006 | 134057685 | 501(C)(3) | $10,000 | RESEARCH |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 142 | Total501c3OrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PROCEDURES FOR MONITORING THE USE OF GRANTS | FormAndLineReferenceDesc |
| Explanation | SCHEDULE I PART I LINE 2 SUSAN G. KOMEN'S (KOMEN) POLICIES FOR MANAGING GRANTS FROM THE TIME OF PRE-AWARD THROUGH CLOSEOUT ARE DESIGNED TO MAXIMIZE FLEXIBILITY WHILE MAINTAINING A HIGH STANDARD OF ACCOUNTABILITY AND PRESERVING THE INTEGRITY OF THE REVIEW AND AWARD PROCESS. KOMEN REQUIRES ALL GRANTEES TO SIGN A GRANT AGREEMENT SETTING FORTH THE TERMS OF THE GRANT, INCLUDING: PURPOSE, AMOUNT, BUDGETARY RESTRICTIONS, DURATION, PAYMENT SCHEDULE, REPORTING REQUIREMENTS, AUDIT, AND EARLY TERMINATION RIGHTS. FOR RESEARCH GRANTS, SCIENTIFIC PROGRESS AND FINANCIAL OVERSIGHT IS MONITORED THROUGHOUT THE GRANT TERM BY A PH.D.-LEVEL RESEARCH GRANT MANAGER. FOR EDUCATION, SCREENING, AND TREATMENT GRANTS, PROGRESS AND FINANCIAL OVERSIGHT IS MONITORED OR SUPERVISED THROUGHOUT THE GRANT TERM BY QUALIFIED PROFESSIONALS SERVING AS GRANTS MANAGERS. EACH YEAR OF THE GRANT TERM, GRANTEES ARE REQUIRED TO SUBMIT PROGRESS AND FINANCIAL REPORTS DETAILING PROGRESS TOWARD AIMS AND OBJECTIVES, MAJOR ACCOMPLISHMENTS, KEY DELIVERABLES AND CHALLENGES ENCOUNTERED, WITH A FULL ACCOUNTING OF GRANT FUNDS EXPENDED (ACTUAL VERSUS BUDGETED EXPENSES) AND WRITTEN JUSTIFICATION OF EXPENSES. AS APPROPRIATE, THE GRANTS MANAGER MAY CONDUCT SITE VISITS WITH GRANTEES TO GAIN A BETTER UNDERSTANDING OF THEIR WORK AND ADDRESS ANY CHALLENGES IMPACTING THE FUNDED PROGRAM. ALL GRANT FUNDS MUST BE EXPENDED IN ACCORDANCE WITH THE PROJECT'S APPROVED BUDGET AND ARE DISBURSED IN ACCORDANCE WITH THE SCHEDULE DOCUMENTED WITHIN THE GRANT AGREEMENT. REQUESTS FOR CHANGES TO THE DESIGN OF THE FUNDED PROJECT OR BUDGET ARE SUBJECT TO PRIOR APPROVAL BY KOMEN IN ACCORDANCE WITH THE TERMS OF THE GRANT AGREEMENT. AS PART OF ITS OVERSIGHT PRACTICES, THE TERMS OF THE GRANT AGREEMENT MAY PROVIDE KOMEN WITH, AMONG OTHER THINGS, THE RIGHT TO REQUEST WITH REASONABLE PRIOR NOTICE TO THE GRANTEE: (1) ADDITIONAL PROGRESS AND/OR FINANCIAL REPORTING FROM THE GRANTEE, (2) GRANTEE PARTICIPATION IN SITE VISITS, TELEPHONE CONFERENCES, PRESENTATIONS, OR OTHER SPEAKING ENGAGEMENTS, AND (3) WITH PRIOR WRITTEN NOTICE, ADJUSTMENT TO THE PROJECT REPORTING PERIOD AND ASSOCIATED DISBURSEMENT OF GRANT FUNDS AT ANY TIME DURING THE GRANT TERM. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Written Employment Contract | Yes (X) | WrittenEmploymentContractInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (true) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | false | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | false | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (14 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Robert Green | |||||||||||
| Chief Financial Officer | $279,292 | $5,092 | $8,644 | $0 | $2,165 | $0 | $295,193 | $0 | $0 | $0 | |
| Adam Vanek BEG 417 | |||||||||||
| Gen. Counsel & Asst Corp Secy | $164,539 | $1,624 | $0 | $0 | $23,926 | $0 | $190,089 | $0 | $0 | $0 | |
| Ellen Willmott | |||||||||||
| INTERIM CEO (END 10/17) | $341,849 | $3,882 | $15,973 | $0 | $10,866 | $0 | $407,295 | $0 | $0 | $0 | $34,725 |
| Christina Alford | |||||||||||
| SVP, Development | $280,188 | $2,100 | $14,385 | $0 | $4,930 | $0 | $301,603 | $0 | $0 | $0 | |
| Victoria Wolodzko | |||||||||||
| VP Research and Com. Health Pr | $183,156 | $2,370 | $10,914 | $0 | $10,693 | $0 | $207,133 | $0 | $0 | $0 | |
| Lori Maris | |||||||||||
| SVP, Affiliate Network | $167,873 | $2,559 | $7,370 | $0 | $11,415 | $0 | $189,217 | $0 | $0 | $0 | |
| Eric Montgomery | |||||||||||
| VP, I.T. | $192,148 | $1,995 | $9,526 | $0 | $37,127 | $0 | $240,796 | $0 | $0 | $0 | |
| Catherine Olivieri | |||||||||||
| VP, Human Resources | $215,234 | $2,802 | $13,834 | $0 | $38,380 | $0 | $270,250 | $0 | $0 | $0 | |
| Andrea Rader | |||||||||||
| Sr Dir, Com. (End 04/18) | $169,826 | $2,943 | $10,481 | $0 | $17,968 | $0 | $201,218 | $0 | $0 | $0 | |
| Ria Williams | |||||||||||
| Controller | $170,058 | $2,001 | $8,369 | $0 | $34,131 | $0 | $214,559 | $0 | $0 | $0 | |
| Subhendu Rath | |||||||||||
| Sr Dir, IT Enterprise Systems | $163,037 | $1,762 | $9,912 | $0 | $18,785 | $0 | $193,496 | $0 | $0 | $0 | |
| Vanessa Hewitt | |||||||||||
| Sr Dir, Internal Audit | $156,643 | $1,795 | $9,856 | $0 | $20,704 | $0 | $188,998 | $0 | $0 | $0 | |
| Kimberly Sabelko | |||||||||||
| Sr Dir, Scientific Strategy | $152,257 | $2,498 | $9,132 | $0 | $21,149 | $0 | $185,036 | $0 | $0 | $0 | |
| Dr Judith Salerno | |||||||||||
| Former President & CEO | $0 | $271,623 | $0 | $0 | $0 | $0 | $271,623 | $0 | $0 | $0 | |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | FORM 990, SCHEDULE J, PART I, LINE 1A | FormAndLineReferenceDesc |
| Explanation | SUPPLEMENTAL COMPENSATION INFORMATION EXCEPT AS MAY BE APPROVED IN ADVANCE FOR MEDICAL ACCOMMODATION, FIRST CLASS AND BUSINESS CLASS FARES FOR DOMESTIC TRAVEL, CANADA, THE CARIBBEAN, CENTRAL AMERICA, AND MEXICO ARE NOT REIMBURSABLE. HOWEVER, PERSONAL FREQUENT FLIER MILEAGE AND/OR COUPONS MAY BE USED FOR NO-COST UPGRADES. IN THE EVENT OF INTERNATIONAL TRAVEL WITH FLIGHT TIMES OF SIX HOURS OR MORE, AND PRE-APPROVAL BUSINESS OR FIRST CLASS TRAVEL MAY BE PERMITTED IF THERE IS A MEDICAL ACCOMODATION OR BUSINESS PURPOSE. WHENEVER POSSIBLE, DISCOUNTED FIRST CLASS AND UPGRADES ARE USED TO MINIMIZE COST. FORM 990, SCHEDULE J, PART I, LINE 4A Dr. Judith Salerno received a severance payment of $271,623. | ExplanationTxt |
Schedule M IRS990ScheduleM
| Field | Value | IRS element (for citing) |
|---|---|---|
| Works Of Art | WorksOfArtGrp | |
| Art Historical Treasures | ArtHistoricalTreasuresGrp | |
| Art Fractional Interest | ArtFractionalInterestGrp | |
| Books And Publications | BooksAndPublicationsGrp | |
| Clothing And Household Goods | ClothingAndHouseholdGoodsGrp | |
| Cars And Other Vehicles | CarsAndOtherVehiclesGrp | |
| Boats And Planes | BoatsAndPlanesGrp | |
| Intellectual Property | IntellectualPropertyGrp | |
| Securities Publicly Traded | SecuritiesPubliclyTradedGrp | |
| Securities Closely Held Stock | SecuritiesCloselyHeldStockGrp | |
| Secur Prtnrshp Trust Intrsts | SecurPrtnrshpTrustIntrstsGrp | |
| Securities Miscellaneous | SecuritiesMiscellaneousGrp | |
| Qualified Contrib Hist Struct | QualifiedContribHistStructGrp | |
| Qualified Contrib Other | QualifiedContribOtherGrp | |
| Real Estate Residential | RealEstateResidentialGrp | |
| Real Estate Commercial | RealEstateCommercialGrp | |
| Real Estate Other | RealEstateOtherGrp | |
| Collectibles | CollectiblesGrp |
Food Inventory FoodInventoryGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 3800 | ContributionCnt |
| Noncash Contributions Rpt F990 | $14,577 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | FMV | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Drugs And Medical Supplies | DrugsAndMedicalSuppliesGrp | |
| Taxidermy | TaxidermyGrp | |
| Historical Artifacts | HistoricalArtifactsGrp | |
| Scientific Specimens | ScientificSpecimensGrp | |
| Archaeological Artifacts | ArchaeologicalArtifactsGrp |
Other Non Cash Contri Table OtherNonCashContriTableGrp (3 entries)
| Non Cash CheckboxNonCashCheckboxInd | DescDesc | ContributionContributionCnt | Noncash Contributions Rpt F990NoncashContributionsRptF990Amt | Method Of Determining RevenuesMethodOfDeterminingRevenuesTxt |
|---|---|---|---|---|
| Yes (X) | Tablecloths & Flowers | 16 | $3,568 | FMV |
| Yes (X) | Exercise Supplies | 20 | $1,035 | FMV |
| Yes (X) | Golf Equip Inventory | 8559 | $207,017 | FMV |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | Yes (true) | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | false | ThirdPartiesUsedInd |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (8 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| VOLUNTEERS | FORM 990, PART I, LINE 6 VOLUNTEERS SERVE IN A VARIETY OF WAYS, BUT THE GREATEST NUMBERS OF VOLUNTEERS ASSIST WITH THE SUSAN G. KOMEN 3 DAY SERIES. FORM 990, PART III - PROGRAM SERVICE ACCOMPLISHMENTS SUSAN G. KOMEN IS A LEADING GLOBAL BREAST CANCER ORGANIZATION, HAVING FUNDED MORE BREAST CANCER RESEARCH THAN ANY OTHER NONPROFIT OUTSIDE THE U.S. GOVERNMENT WHILE PROVIDING REAL TIME HELP TO THOSE FACING THE DISEASE. SINCE ITS FOUNDING IN 1982, KOMEN HAS FUNDED MORE THAN $988 MILLION IN BREAST CANCER RESEARCH AND PROVIDED OVER $2.2 BILLION IN FUNDING FOR PATIENT NAVIGATION, SCREENING, DIAGNOSIS, TREATMENT, EDUCATION, HEALTH SYSTEMS IMPROVEMENT, AND PSYCHOSOCIAL SUPPORT PROGRAMS SERVING MILLIONS OF PEOPLE IN MORE THAN 60 COUNTRIES WORLDWIDE. KOMEN WAS FOUNDED BY NANCY G. BRINKER, WHO PROMISED HER SISTER, SUSAN G. KOMEN, THAT SHE WOULD END THE DISEASE THAT CLAIMED SUZY'S LIFE. RESEARCH SINCE ITS FOUNDING IN 1982, KOMEN'S RESEARCH INVESTMENTS HAVE CONTRIBUTED TO MAJOR ADVANCES IN BREAST CANCER SCIENCE. THE PROGRESS HAS BEEN SIGNIFICANT - TODAY, WE KNOW THAT BREAST CANCER IS MORE THAN A SINGLE DISEASE. WE HAVE A BETTER UNDERSTANDING OF THE GENETICS OF BREAST CANCER AND THE CRITICAL NEED TO TAILOR SCREENING, DIAGNOSIS, TREATMENT, AND PREVENTION STRATEGIES TO INDIVIDUALS THROUGH ADVANCES IN PRECISION MEDICINE. KOMEN'S RESEARCH PROGRAMS ARE FOCUSED ON BREAKTHROUGH RESEARCH TO PREVENT AND CURE BREAST CANCER THROUGH BETTER APPROACHES FOR EARLY DETECTION AND DIAGNOSIS, UNDERSTANDING METASTASIS AND RECURRENCE, AND DEVELOPING NOVEL THERAPIES FOR ALL STAGES OF BREAST CANCER, WITH THE GOAL OF SUPPORTING WORK THAT HAS SIGNIFICANT POTENTIAL TO LEAD TO NEW TREATMENTS AND TECHNOLOGIES THAT WILL REDUCE THE NUMBER OF BREAST CANCER DEATHS IN THE U.S. BY 50 PERCENT BY 2026. KOMEN'S RESEARCH PROGRAMS ARE GUIDED BY 60 OF THE WORLD'S LEADERS IN BREAST CANCER RESEARCH, ONCOLOGY AND ADVOCACY. THE SCIENTIFIC ADVISORY BOARD ASSISTS KOMEN IN SETTING ITS RESEARCH STRATEGY AND PRIORITIZING ITS RESEARCH INVESTMENT. THE KOMEN SCHOLARS LEAD AND PARTICIPATE IN KOMEN'S WORLD-CLASS SCIENTIFIC PEER REVIEW PROCESS. OUR ADVOCATES IN SCIENCE BRING THE PATIENT VOICE TO KOMEN'S RESEARCH PROGRAMS, EMPHASIZING URGENCY AND PATIENT IMPACT. KOMEN AWARDS GRANTS TO INDIVIDUAL SCIENTISTS, RESEARCH TEAMS, AND ORGANIZATIONS AROUND THE WORLD THROUGH A FAIR, TRANSPARENT, RIGOROUS, AND COMPETITIVE REVIEW PROCESS THAT ENSURES MAXIMUM IMPACT FOR OUR RESEARCH INVESTMENT. IN FY18, KOMEN AWARDED MORE THAN 60 GRANTS THROUGH ITS RESEARCH PROGRAMS TO SUPPORT SCIENTIFIC RESEARCH, COLLABORATIONS AND TRAINING IN THE UNITED STATES AND OTHER COUNTRIES, INCLUDING AUSTRALIA, CANADA, FRANCE, AND IRELAND. WE CONSIDER IT OUR RESPONSIBILITY TO ENSURE THE CONTINUITY OF BREAST CANCER RESEARCH FOR THE FUTURE. WITH FEDERAL RESEARCH BUDGETS TIGHTENING, THE PUBLIC CANNOT AFFORD TO LOSE PROMISING YOUNG INVESTIGATORS DUE TO A LACK OF FUNDING OPPORTUNITIES. TO THAT END, KOMEN AWARDED CAREER CATALYST RESEARCH GRANTS (WITH A COMPETITIVE RENEWAL OPTION) TO SUPPORT YOUNG INVESTIGATORS IN BREAST CANCER RESEARCH ADDRESSING TWO OF THE GREATEST CHALLENGES FACING BREAST CANCER PATIENTS -DRUG-RESISTANT BREAST CANCERS AND NEW APPROACHES TO COMBAT METASTATIC BREAST CANCER. KOMEN ALSO OFFERED LEADERSHIP GRANTS AND A PHASE II COMPETITIVE RENEWAL OF THE INFLAMMATORY BREAST CANCER RESEARCH INNOVATOR GRANTS. EACH MECHANISM IS FURTHER DESCRIBED BELOW: CAREER CATALYST RESEARCH GRANTS (CCR): CCR GRANTS PROVIDE UNIQUE OPPORTUNITIES FOR SCIENTISTS WHO HAVE HELD FACULTY POSITIONS FOR NO MORE THAN 5 YEARS AT THE TIME OF FULL APPLICATION TO ACHIEVE RESEARCH INDEPENDENCE. THE GOAL OF THE FY18 CCR GRANTS IS TO SUPPORT OUTSTANDING TRANSLATIONAL RESEARCH FOCUSED ON THOSE BREAST CANCERS THAT DO NOT CURRENTLY RESPOND WELL TO STANDARD THERAPIES INCLUDING TRIPLE NEGATIVE BREAST CANCER (TNBC), ER+ BREAST CANCER WITH ACQUIRED RESISTANCE, AND METASTATIC BREAST CANCER OF ALL SUB-TYPES. CCR GRANTS SUPPORT WORK THAT HAS SIGNIFICANT POTENTIAL TO LEAD TO NEW TREATMENTS AND TECHNOLOGIES THAT WILL REDUCE THE NUMBER OF BREAST CANCER DEATHS IN THE U.S. BY 50 PERCENT BY 2026. CAREER CATALYST RESEARCH GRANTS-COMPETING RENEWALS (CCR-CR): CCR-CR GRANTS WERE DESIGNED TO ADDRESS THE INTENSE COMPETITION AND LACK OF FUNDING THAT MAY CAUSE TALENTED YOUNG SCIENTISTS TO LEAVE THE FIELD. CCR-CR GRANTS ARE INTENDED TO PROVIDE CONTINUED SUPPORT TO EARLY CAREER BREAST CANCER RESEARCHERS AND CLINICIAN-SCIENTISTS WHO HAVE HAD PRIOR KOMEN CCR GRANT SUPPORT, BUT HAVE NOT YET SECURED SUPPORT AS A PRINCIPAL INVESTIGATOR THROUGH A NATIONAL INSTITUTES OF HEALTH R01 AWARD OR OTHER INDEPENDENT AWARD SIMILAR IN SCOPE. IT IS EXPECTED THAT AWARDEES WILL LEVERAGE THE CCR-CR GRANT TO SUCCESSFULLY COMPETE FOR ADDITIONAL INDEPENDENT RESEARCH FUNDING IN BREAST CANCER, AND THUS REMAIN IN THE FIELD. INFLAMMATORY BREAST CANCER (IBC) RESEARCH INNOVATOR GRANTS: GENEROUSLY SUPPORTED BY THE MILBURN FOUNDATION AND THE INFLAMMATORY BREAST CANCER RESEARCH FOUNDATION, THESE INNOVATOR GRANTS ARE INTENDED TO SPUR IDEAS THAT WILL INCREASE THE UNDERSTANDING OF HOW IBC CAN BE BETTER DIAGNOSED AND HOW BIOLOGY DRIVES ITS PROGRESSION, THEREBY LEADING TO IMPROVED PROGNOSIS AND MORE EFFECTIVE TREATMENTS FOR THOSE WITH THIS AGGRESSIVE DISEASE. THIS PROGRAM CONSISTED OF TWO STAGES. IN THE FIRST STAGE, ONE YEAR OF FUNDING WAS AWARDED TO ALLOW INVESTIGATORS TO ESTABLISH THE FOUNDATION OF A ROBUST AND INNOVATIVE IBC RESEARCH PROJECT. IN THE SECOND STAGE, AWARDEES COMPETED FOR ADDITIONAL FUNDING TO BUILD ON THEIR ORIGINAL PROJECT AND ONE GRANT WAS FUNDED. LEADERSHIP GRANTS: LEADERSHIP GRANTS PROVIDE SUPPORT FOR HYPOTHESIS-DRIVEN RESEARCH PROJECTS CONDUCTED BY THE DISTINGUISHED BREAST CANCER RESEARCHERS AND CLINICIANS WHO SERVE AS KOMEN'S SCIENTIFIC ADVISORS AND SEEK TO DISCOVER AND DELIVER THE CURES FOR BREAST CANCER. OPPORTUNITY GRANTS / STRATEGIC PARTNERSHIP AND PROGRAM GRANTS (OG/SPP): OG AND SPP GRANTS SUPPORT SPECIAL RESEARCH PROJECTS, PROGRAMS, AND COLLABORATIONS THAT LEVERAGE RESEARCH AND COMMUNITY RESOURCES TO FACILITATE THE DEVELOPMENT OF THE INFRASTRUCTURE, TOOLS, AND OTHER MEANS TO ACCELERATE THE TRANSLATION OF SCIENTIFIC DISCOVERIES FROM BENCH TO BEDSIDE TO CURBSIDE. FUNDING FROM ORGANIZATIONS LIKE KOMEN AND ITS SUPPORTERS HAS PROVEN CRITICAL FOR ALL THESE ACTIVITIES, ESPECIALLY AT A TIME OF DIMINISHING FEDERAL FUNDING FOR CANCER RESEARCH AND FOR CLINICAL TRIALS. KOMEN'S RESEARCH INVESTMENT THROUGH THESE GRANT MECHANISMS SUPPORTS PROJECTS THAT AIM TO, AMONG OTHER THINGS: (A) DEVELOP TARGETED THERAPIES;(B) OVERCOME AGGRESSIVE TYPES OF BREAST CANCER AND METASTASIS; (C) OVERCOME TREATMENT RESISTANCE; AND (D) UNDERSTAND AND ADDRESS DISPARITIES IN OUTCOMES. |
| EXAMPLES OF RESEARCH GRANTS AWARDED IN FY18 INCLUDE: | A) TARGETED THERAPIES FOR TRIPLE-NEGATIVE BREAST CANCER: DR. SOHRAB SHAH FROM MEMORIAL SLOAN-KETTERING CANCER CENTER WAS AWARDED A LEADERSHIP GRANT TO COMBINE AND ANALYZE GENOMIC AND CLINICAL DATA FROM APPROXIMATELY 300 PATIENTS WITH TRIPLE NEGATIVE BREAST CANCER (TNBC) TO STUDY HOW MUTATIONS IN THE DNA OF TNBC CELLS CAN BE USED TO DESIGN BETTER TREATMENT APPROACHES. USING STATE-OF-THE-ART DNA SEQUENCING TECHNOLOGIES, DR. SHAH WILL MEASURE THE DNA OF INDIVIDUAL CANCER CELLS TO CREATE AN ULTRA-DETAILED PICTURE OF HOW TNBC CHANGES OVER TIME. THESE DETAILED VIEWS WILL REVEAL PREVIOUSLY UNSEEN PATTERNS OF DNA MUTATIONS IN TNBC, WHICH WILL BE USED TO STRATIFY PATIENTS INTO BIOLOGICALLY DISTINCT SUBGROUPS WITH DIFFERENT SENSITIVITIES TO CHEMOTHERAPY. THE DATA GENERATED FROM HIS PROJECT WILL BE USED TO HELP STRATIFY PATIENTS ACCORDING TO TREATMENT RESPONSE AND OUTCOMES, POTENTIALLY DIRECTING PATIENTS TO MORE TARGETED THERAPIES, WHICH ARE CURRENTLY LACKING FOR TNBC. B) OVERCOME AGGRESSIVE TYPES OF BREAST CANCER AND METASTASIS: DR. XIA LIU FROM NORTHWESTERN UNIVERSITY'S FEINBERG SCHOOL OF MEDICINE WAS AWARDED A CCR GRANT TO TEST WHETHER TWO NATURAL COMPOUNDS - HYPERFORIN AND BOSWELLIA - CAN BE USED ALONE OR IN COMBINATION WITH ANOTHER IMMUNOTHERAPY, A CHECKPOINT INHIBITOR CALLED ANTI PD-1 ANTIBODY, TO PREVENT THE ABILITY OF NEUTROPHILS TO PROMOTE METASTASIS. HYPERFORIN IS A PLANT-DERIVED ANTIBIOTIC FROM ST. JOHN'S WORT AND BOSWELLIA IS A PLANT THAT PRODUCES INDIAN FRANKINCENSE. DR. LIU WILL ALSO CONDUCT STUDIES TO UNCOVER HOW NEUTROPHILS INTERACT WITH TUMOR CELLS IN THE BLOOD TO PROMOTE METASTASIS. SHE WILL IDENTIFY THE MOLECULES THAT FACILITATE THIS INTERACTION AND DETERMINE WHETHER THESE MOLECULES CAN SERVE AS BIOMARKERS TO PREDICT METASTASIS IN PATIENTS WITH TRIPLE NEGATIVE BREAST CANCER, HELPING TO GUIDE TREATMENT STRATEGIES. C) OVERCOME TREATMENT RESISTANCE: DR. SVASTI HARICHARAN AT BAYLOR COLLEGE OF MEDICINE WAS AWARDED A CCR GRANT TO STUDY ENDOCRINE THERAPY RESISTANCE IN ER+ BREAST CANCER. PATIENTS WITH ESTROGEN RECEPTOR-POSITIVE (ER+) BREAST CANCER ARE TREATED WITH ENDOCRINE THERAPY, BUT ABOUT 1/3 OF ER+ PATIENTS DO NOT RESPOND TO THIS TREATMENT AND EVENTUALLY DIE OF THE DISEASE. DR. HARICHARAN HAS DISCOVERED THAT TUMORS WITH DEFECTS IN THEIR ABILITY TO REPAIR MISMATCHES IN DNA ARE RESISTANT TO ENDOCRINE THERAPIES, AND UP TO 30% OF ENDOCRINE TREATMENT RESISTANT TUMORS SHOW THIS DEFECT. DR. HARICHARAN WILL MOVE THIS DISCOVERY INTO THE CLINIC BY 1) DEVELOPING A SIMPLE DIAGNOSTIC TEST SO THAT CLINICIANS CAN IDENTIFY TUMORS WITH DEFECTIVE MISMATCH REPAIR AND 2) IDENTIFYING EXISTING FDA-APPROVED DRUGS THAT CAN TREAT THESE TUMORS MORE EFFECTIVELY THAN ENDOCRINE TREATMENT. THIS STUDY WILL HELP IDENTIFY WOMEN LIKELY TO DEVELOP DRUG RESISTANCE EARLY IN THE TIMELINE OF THEIR CANCER TREATMENT, PROVIDING DOCTORS A CRUCIAL OPPORTUNITY TO PERSONALIZE THERAPY TO EACH PATIENT. D) UNDERSTAND AND ADDRESS DISPARITIES IN OUTCOMES: RACHEL FREEDMAN, M.D., M.P.H., OF DANA-FARBER CANCER INSTITUTE WILL INVESTIGATE WAYS TO IMPROVE SURVIVAL FOR BREAST CANCER PATIENTS THAT ARE 70 YEARS OF AGE OR OLDER. OLDER PATIENTS OFTEN FACE WORSE OUTCOMES WHEN COMPARED TO THEIR YOUNGER COUNTERPARTS. THE GOAL OF THIS STUDY IS TO IDENTIFY TAILORED TREATMENT METHODS THAT WILL IMPROVE SURVIVAL FOR THIS POPULATION OF PATIENTS. KOMEN SCHOLAR JULIE PALMER, SC.D., OF BOSTON UNIVERSITY WILL DEVELOP A RISK PREDICTION TOOL THAT WILL CONSIDER THE DIFFERENT RISK FACTORS FOR ER+ AND ER- BREAST CANCER, ALONG WITH THE DIFFERING AGE INCIDENCE PATTERNS IN AFRICAN AMERICAN WOMEN. THIS TOOL WILL HELP IDENTIFY AFRICAN AMERICAN WOMEN WHO WOULD BENEFIT FROM EARLIER AND MORE FREQUENT SCREENING OR ALTERNATIVE MODES OF SCREENING. EDUCATION AND PATIENT SUPPORT: KOMEN IS A TRUSTED SOURCE OF BREAST CANCER INFORMATION FOR PEOPLE ALL OVER THE WORLD AND IS INSTRUMENTAL IN CONNECTING PEOPLE WITH THE RESOURCES THEY NEED IN THEIR FIGHT AGAINST BREAST CANCER. OUR WEBSITE, KOMEN.ORG, PROVIDES CURRENT, SAFE, ACCURATE, COMPREHENSIVE, AND UNBIASED INFORMATION ABOUT BREAST CANCER, BASED ON SCIENTIFIC EVIDENCE. CONTENT IS OFFERED IN A VARIETY OF FORMATS INCLUDING INTERACTIVE VIDEO USING ANIMATION AND VOICEOVER IN ENGLISH AND SPANISH, ILLUSTRATIONS, CHARTS, GRAPHS, AND SHORT VIDEOS TO MEET THE LEARNING PREFERENCES AND NEEDS OF OUR WEB VISITORS. THE "ABOUT BREAST CANCER" SECTION OF KOMEN'S WEBSITE, CO-DEVELOPED WITH HARVARD MEDICAL SCHOOL FACULTY AND DANA-FARBER/BRIGHAM AND WOMEN'S CANCER CENTER STAFF, RECEIVED MORE THAN 5.6 MILLION PAGE VIEWS DURING FY18. KOMEN ALSO PROVIDES EVIDENCE-BASED, EASY-TO-READ EDUCATIONAL MATERIALS IN DOWNLOADABLE FORMATS ON KOMEN.ORG. EXAMPLES OF KOMEN EDUCATIONAL MATERIALS INCLUDE: A) BREAST SELF-AWARENESS MESSAGE CARDS IN MORE THAN 40 LANGUAGES, B) BREAST CANCER SPECIFIC BROCHURES AND FACTSHEETS, C) BOOKLETS WITH SUPPORT INFORMATION FOR SURVIVORS AND CO-SURVIVORS, AND D) TOOLKITS FOR BREAST CANCER OUTREACH AND EDUCATION FOR HISPANIC/LATINO IN ENGLISH AND SPANISH AND FOR BLACK AND AFRICAN-AMERICAN COMMUNITIES. THE SUSAN G. KOMEN "1-877 GO KOMEN" (1-877-465-6636) BREAST CARE HELPLINE OFFERS BREAST CANCER EDUCATION, PSYCHOSOCIAL SUPPORT, AND INFORMATION ABOUT COMMUNITY RESOURCES FOR PATIENTS, FAMILIES, AND FRIENDS. IN FY18, KOMEN ADDED A CLINICAL TRIAL INFORMATION HELPLINE TO PROVIDE INFORMATION, RESOURCES, COACHING AND SUPPORT RELATED TO BREAST CANCER CLINICAL TRIALS. THE HELPLINE OPERATES FROM 9 A.M. - 10 P.M. E.T. THE SERVICE IS OFFERED IN ENGLISH, SPANISH, AND TAGALOG. DURING FY18, THE KOMEN BREAST CANCER HELPLINE RESPONDED TO MORE THAN 13,000 CALLS AND EMAILS. IN ADDITION, IN FY18 KOMEN SUPPORTED TWO NONPROFIT ADVOCACY ORGANIZATIONS TO PRESENT PATIENT-FOCUSED, EDUCATIONAL CONFERENCES DEDICATED TO THE CRITICAL ISSUES FACING BREAST CANCER PATIENTS AND THEIR FAMILIES. KOMEN FUNDS THE LIVING BEYOND BREAST CANCER'S (LBBC) CONFERENCE FOR WOMEN LIVING WITH METASTATIC BREAST CANCER IN THE WASHINGTON, D.C. REGION. THE CONFERENCE BRINGS PEOPLE WITH METASTATIC BREAST CANCER, CAREGIVERS, HEALTHCARE PROFESSIONALS, HEALTHCARE ORGANIZATIONS, SUPPORT ORGANIZATIONS AND OTHERS, WHO PARTICIPATE IN THE CARE OF PATIENTS WITH METASTATIC BREAST CANCER, TO DISCUSS SCIENTIFIC BREAKTHROUGHS, ONGOING CLINICAL TRIALS, QUALITY OF LIFE, AND INTEGRATIVE MEDICINE. THE CONFERENCE IS DESIGNED TO FILL THE NEEDS OF THE METASTATIC BREAST CANCER COMMUNITY AND SEEKS TO STRENGTHEN METASTATIC BREAST CANCER VOICES IN THE NATIONAL CAPITAL REGION BY CREATING OPPORTUNITIES FOR LEARNING, ENGAGEMENT AND ACTION. BREAST CANCER IS THE MOST COMMON CANCER IN WOMEN, WORLDWIDE, AND THE NUMBER OF CASES IS INCREASING IN NEARLY EVERY COUNTRY. THE NUMBER OF NEW BREAST CANCER CASES HAS MORE THAN DOUBLED AROUND THE WORLD IN THE LAST THREE DECADES, WITH HIGHEST INCREASES OBSERVED IN LOW- AND MIDDLE-INCOME COUNTRIES. BREAST CANCER IS ALSO THE LEADING CAUSE OF CANCER DEATH IN THESE COUNTRIES, WITH OVER 500,000 DEATHS IN 2012. THESE TRENDS ARE CONCERNING, WHICH IS WHY KOMEN WORKS TIRELESSLY TO PROVIDE SUPPORT TO BREAST HEALTH PROGRAMS WORLDWIDE. IT TAKES COLLABORATION AND STRONG PARTNERSHIPS TO MAKE A GLOBAL IMPACT. KOMEN STRIVES TO SERVE AS A "BRIDGE" - COLLABORATING WITH INTERNATIONAL NONPROFITS, CORPORATIONS, AND MINISTRIES OF HEALTH TO BRING TOGETHER PEOPLE AND ORGANIZATIONS TO DEVELOP PROGRAMS THAT ARE TAILORED TO THE SPECIFIC NEEDS OF THE COMMUNITY AND SENSITIVE TO CULTURAL DIFFERENCES. IN FY18, KOMEN'S GLOBAL PROGRAM AWARDED TEN GRANTS TO SUPPORT EDUCATION PROGRAMMING FOR PATIENTS AND FOR HEALTH PROFESSIONALS AND TO REDUCE BARRIERS TO BREAST CANCER CARE IN CHINA, COLOMBIA, MEXICO, PANAMA, AND ZAMBIA. IN ZAMBIA, SUSAN G. KOMEN PARTNERED WITH CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA (CIDRZ) TO CONVENE THE CANCER PREVENTION ALLIANCE OF ZAMBIA (CAPRAZ). THIS COUNTRY-WIDE ALLIANCE OF CANCER ADVOCACY GROUPS WILL WORK TO INTENSIFY BREAST AND CERVICAL CANCER EDUCATION CAMPAIGNS IN COMMUNITIES TO DISPEL MYTHS AND MISCONCEPTIONS; ENSURE THE BREAST AND CERVICAL CANCER HEALTH PROMOTION MESSAGES ARE EVIDENCE-BASED AND CONTEXTUALLY RELEVANT; AND COORDINATE AND PROVIDE TECHNICAL SUPPORT FOR EDUCATION ACTIVITIES OF MEMBER GROUPS. |
| PUBLIC POLICY AND ADVOCACY | SUSAN G. KOMEN IS THE VOICE FOR THE MORE THAN 3.5 MILLION BREAST CANCER SURVIVORS AND THOSE WHO LOVE THEM. KOMEN WORKS TO ENSURE THAT THE FIGHT AGAINST BREAST CANCER IS A PRIORITY AMONG POLICYMAKERS IN WASHINGTON, D.C., AND EVERY STATE CAPITOL ACROSS THE COUNTRY. EVERY TWO YEARS, THROUGH A TRANSPARENT, BROAD-BASED AND INTENSIVE VETTING AND SELECTION PROCESS, KOMEN WORKS TO IDENTIFY THE POLICY ISSUES WITH THE GREATEST POTENTIAL MISSION IMPACT. THIS PROCESS INCLUDES COLLECTING FEEDBACK FROM KOMEN HEADQUARTERS' LEADERSHIP, POLICY STAFF, AND SUBJECT MATTER EXPERTS; KOMEN AFFILIATES FROM ACROSS THE COUNTRY; ADVISORY GROUPS INCLUDING ADVOCATES IN SCIENCE (AIS) AND KOMEN SCHOLARS; AND OTHER STAKEHOLDERS WITH A VESTED INTEREST IN BREAST CANCER-RELATED ISSUES. THE SELECTED ISSUES ARE THE BASIS FOR KOMEN'S STATE AND FEDERAL ADVOCACY. KOMEN'S 2017-2018 ADVOCACY PRIORITIES INCLUDED: SUPPORTING EXPANDED FEDERAL FUNDING FOR BREAST CANCER RESEARCH AT THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE DEPARTMENT OF DEFENSE (DOD); SUPPORTING STATE AND FEDERAL FUNDING FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION'S (CDC) NATIONAL BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM (NBCCEDP); ADVOCATING FOR STATE AND FEDERAL POLICIES TO IMPROVE INSURANCE COVERAGE OF BREAST CANCER TREATMENTS, INCLUDING THOSE THAT WOULD REQUIRE ORAL PARITY, PRECLUDE SPECIALTY TIERS AND PREVENT STEP THERAPY PROTOCOLS; ADVOCATING FOR STATE AND FEDERAL POLICIES TO REDUCE OR ELIMINATE OUT-OF-POCKET COSTS FOR MEDICALLY NECESSARY DIAGNOSTIC MAMMOGRAPHY; AND EVALUATING STATE AND FEDERAL POLICIES TO INCREASE PUBLIC ACCESS TO INFORMATION ABOUT AND PARTICIPATION IN CLINICAL TRIALS FOR ALL PATIENT POPULATIONS. IN ADDITION TO THE STATE AND FEDERAL WORK ON OUR 2017-2018 ADVOCACY PRIORITIES, KOMEN CONTINUED OUR EFFORTS TO ENSURE EVERY BREAST CANCER PATIENT AND SURVIVOR HAS ACCESS TO AFFORDABLE, QUALITY HEALTH INSURANCE AND CARE. KOMEN ALSO ENGAGED ON ISSUES RELATED TO BREAST DENSITY, COMPASSIONATE USE, GENETIC TESTING, HEALTH DISPARITIES, LYMPHEDEMA, METASTATIC BREAST CANCER, PALLIATIVE CARE AND SURVIVORSHIP. KOMEN DEVELOPED AND IMPLEMENTED ADVOCACY CAMPAIGNS TO ENCOURAGE LAWMAKERS AND AGENCY OFFICIALS TO SUPPORT AND IMPLEMENT PROGRAMS THAT WOULD ADVANCE OUR PRIORITY ISSUES AND ADDITIONAL POLICY AREAS TO ACHIEVE KOMEN'S BOLD GOAL. KOMEN CONTINUED TO RECRUIT AND ENGAGE ADVOCATES TO FURTHER STRENGTHEN ITS GRASSROOTS ADVOCACY NETWORK. SCREENING AND PATIENT NAVIGATION GETTING REGULAR SCREENING TESTS, ALONG WITH EFFECTIVE AND QUALITY TREATMENT IF DIAGNOSED, LOWERS THE RISK OF DYING FROM BREAST CANCER. SCREENING TESTS CAN FIND BREAST CANCER EARLY, WHEN CHANCES FOR SURVIVAL ARE HIGHEST. PATIENT NAVIGATION IS A PROCESS BY WHICH AN INDIVIDUAL - A PATIENT NAVIGATOR - GUIDES PATIENTS THROUGH AND AROUND BARRIERS IN THE COMPLEX CANCER CARE SYSTEM. EVIDENCE SHOWS NAVIGATION IMPROVES ADHERENCE TO SCREENING RECOMMENDATIONS, AND THUS IMPROVES OVERALL OUTCOMES. KOMEN SUPPORTS FREE AND LOW-COST SCREENING PROGRAMS IN UNDERSERVED COMMUNITIES THAT HELP NAVIGATE PEOPLE TO QUALITY CARE, AND/OR PROVIDE COVERAGE FOR SCREENING SERVICES TO PEOPLE WITHOUT HEALTH INSURANCE, OR THOSE WITH HIGH CO-PAYS AND DEDUCTIBLES THAT MAKE SCREENING TOO COSTLY. IN FY18, KOMEN AWARDED ONE SCREENING COMMUNITY GRANT TO THE AMERICAN ASSOCIATION ON HEALTH AND DISABILITY. THE PROJECT FOCUSES ON WOMEN WITH DISABILITIES IN WASHINGTON D.C., PARTICULARLY BLACK AND AFRICAN-AMERICAN WOMEN, WITH THE ULTIMATE GOAL OF INCREASING BREAST CANCER CARE UTILIZATION THROUGH DECREASING BARRIERS TO ACCESS CARE, LEADING TO REDUCED MORTALITY. THROUGH ITS GLOBAL PROGRAM, KOMEN AWARDED TEN GRANTS TO COMMUNITY ORGANIZATIONS IN SUPPORT OF SCREENING AND PATIENT NAVIGATION PROGRAMS IN MEXICO, PANAMA, CHINA, COLUMBIA, AND ZAMBIA. TREATMENT AND PATIENT NAVIGATION BARRIERS TO QUALITY CARE ARE OFTEN ASSOCIATED WITH POOR BREAST CANCER OUTCOMES AND RESULTANT CANCER DISPARITIES AMONG SPECIFIC POPULATION GROUPS. ACCORDING TO QUALITATIVE DATA COLLECTED FROM ACROSS KOMEN'S AFFILIATE NETWORK, THE MOST COMMON BARRIERS TO QUALITY CARE IN THE UNITED STATES INCLUDE: (1) AVAILABILITY OF LOCAL SERVICES; (2) BREAST CANCER EDUCATION; (3) CULTURAL/LANGUAGE; (4) FEAR; (5) FINANCIAL; (6) INSURANCE; (7) TRANSPORTATION. PATIENT NAVIGATION IS A PROCESS BY WHICH AN INDIVIDUAL - A PATIENT NAVIGATOR - GUIDES PATIENTS THROUGH AND AROUND BARRIERS IN THE COMPLEX CANCER CARE SYSTEM TO ENSURE TIMELY DIAGNOSIS AND TREATMENT. EVIDENCE SHOWS PATIENT NAVIGATION IMPROVES ADHERENCE TO TREATMENT RECOMMENDATIONS, RESULTING IN IMPROVED OUTCOMES. IN FY18, KOMEN FUNDED THREE NONPROFIT ORGANIZATIONS IN SUPPORT OF PROGRAMS TO REDUCE STRUCTURAL, PERSONAL, SOCIOCULTURAL, AND FINANCIAL BARRIERS TO CARE, AND PROVIDE PATIENT NAVIGATION SERVICES FOR UNDERSERVED COMMUNITIES IN THE WASHINGTON, D.C. METRO AREA, SPECIFICALLY WARDS 2, 5, 7, AND 8, AND ALEXANDRIA CITY, VA. THROUGH ITS GLOBAL PROGRAM IN FY18, KOMEN AWARDED TEN GRANTS TO COMMUNITY ORGANIZATIONS IN SUPPORT OF TREATMENT AND PATIENT NAVIGATION PROGRAMS AND TO REDUCE BARRIERS TO BREAST CANCER CARE IN CHINA, COLOMBIA, MEXICO, PANAMA, AND ZAMBIA. FOR EXAMPLE, KOMEN SUPPORTED CASITA DE MAUSI TO PROVIDE LODGING, TRANSPORTATION, AND MEALS FOR BREAST CANCER PATIENTS FROM RURAL COMMUNITIES IN PANAMA, FACILITATING THEIR ACCESS TO BREAST CANCER SERVICES. KOMEN ALSO SUPPORTED ALIANZA MEXICANA POR EL CNCER IN MEXICO TO IMPROVE THE CURRENT OUTLOOK OF BREAST CANCER IN MEXICO THROUGH THE EARLY DETECTION, DIAGNOSIS, AND TREATMENT OF BREAST CANCER; IMPROVING CLINICAL CARE OF PATIENTS; ENCOURAGING MULTIDISCIPLINARY RESEARCH OF BREAST CANCER IN MEXICO; EXPANDING THE EDUCATION OF THE PUBLIC, PATIENTS, AND HEALTH PROFESSIONALS; AND GUARANTEEING THE REPLICABILITY OF THE PROGRAMS WE FOSTER. KOMEN'S TREATMENT ASSISTANCE PROGRAM, ADMINISTERED BY CANCERCARE, AIMS TO HELP WOMEN AND MEN IN BREAST CANCER TREATMENT WHO ARE FACING FINANCIAL CHALLENGES BY PROVIDING LIMITED FINANCIAL ASSISTANCE, EDUCATION, AND SUPPORT SERVICES. FINANCIAL ASSISTANCE IS GRANTED TO UNDERSERVED, UNDERINSURED OR UNINSURED WOMEN AND MEN ACROSS THE COUNTRY UNDERGOING BREAST CANCER TREATMENT WHO MEET PRE-DETERMINED ELIGIBILITY CRITERIA. THIS PROGRAM PROVIDES FINANCIAL ASSISTANCE FOR TREATMENT-RELATED COSTS, INCLUDING TRANSPORTATION TO AND FROM TREATMENT, CHILD/ELDER CARE, HOME CARE, ORAL PAIN/ANTI-NAUSEA MEDICATIONS, ORAL CHEMOTHERAPY/HORMONE THERAPY, LYMPHEDEMA CARE/SUPPLIES, PALLIATIVE CARE, AND DURABLE MEDICAL EQUIPMENT. WE SERVED MORE THAN 3200 PEOPLE THROUGH THIS PROGRAM IN FY18. EXECUTIVE COMMITTEE FORM 990, PART VI, LINE 1A THE ORGANIZATION'S BYLAWS PROVIDE FOR AN EXECUTIVE COMMITTEE COMPRISED OF A MINIMUM OF FIVE MEMBERS INCLUDING THE BOARD CHAIR, THE PRESIDENT AND CHIEF EXECUTIVE OFFICER, AND ADDITIONAL BOARD MEMBERS, AS RECOMMENDED BY THE GOVERNANCE COMMITTEE AND APPOINTED BY THE BOARD OF DIRECTORS. MEMBERS OF THE EXECUTIVE COMMITTEE MUST EITHER BE DIRECTORS OF THE ORGANIZATION OR THE PRESIDENT AND CHIEF EXECUTIVE OFFICER. THE BYLAWS PROVIDE THE EXECUTIVE COMMITTEE WITH THE AUTHORITY TO: (A) APPOINT MEMBERS TO NON-STANDING COMMITTEES OF THE ORGANIZATION, AND NAME CHAIRS OF SUCH COMMITTEES; (B) AUTHORIZE UNBUDGETED DISBURSEMENTS BY THE ORGANIZATION IN ACCORDANCE WITH THE SPECIFIC EXPENDITURE AUTHORITY PRESCRIBED BY THE BOARD OF DIRECTORS; (C) EMPLOY AGENTS; AND (D) CARRY INTO EXECUTION SUCH OTHER MEASURES AS IT DETERMINES WILL PROMOTE THE PURPOSE OF THE ORGANIZATION. THE COMMITTEE ALSO MAY EXERCISE, WHEN THE BOARD IS NOT IN SESSION, ALL OF THE AUTHORITY OF THE BOARD IN THE MANAGEMENT OF THE BUSINESS AND AFFAIRS OF THE ORGANIZATION WITH CERTAIN EXCEPTIONS SUCH AS REPEALING ANY BOARD RESOLUTIONS, AMENDING THE ORGANIZATION'S ARTICLES OR BYLAWS, OR MERGING OR DISSOLVING THE ORGANIZATION. THIS DELEGATION DOES NOT RELIEVE THE BOARD OF ANY OF ITS RESPONSIBILITIES IMPOSED BY LAW, AND THE COMMITTEE ENDEAVORS TO LIMIT ITS EXERCISE OF AUTHORITY TO TIME SENSITIVE ISSUES. DESCRIBE THE PROCESS USED BY MANAGEMENT &/OR GOVERNING BODY TO REVIEW 990 FORM 990, PART VI, LINE 11B MANAGEMENT PREPARES THE MATERIALS FOR THE FORM 990, WITH THE ASSISTANCE OF AND REVIEW BY EXTERNAL ACCOUNTANTS. SENIOR LEVEL MANAGEMENT REVIEW AND COMMENT ON THE FINAL DRAFT OF THE FORM 990 FOR SUBSEQUENT PRESENTATION TO THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS. THE AUDIT COMMITTEE REVIEWS, MAKES RECOMMENDATIONS, AND APPROVES THE FORM 990 FOR PRESENTATION TO THE BOARD OF DIRECTORS. THEREAFTER, THE BOARD OF DIRECTORS REVIEWS AND APPROVES THE FORM 990 PRIOR TO FILING. |
| DESCRIPTION OF PROCESS TO MONITOR TRANSACTIONS FOR CONFLICTS OF | INTEREST FORM 990, PART VI, LINE 12C KOMEN PRODUCES AN ANNUAL SURVEY REQUIRING ALL EMPLOYEES, BOARD MEMBERS, COMMITTEE MEMBERS, AND ADVISORY BOARD MEMBERS TO DISCLOSE ANY POTENTIAL OR ACTUAL CONFLICTS OF INTEREST THEY MAY HAVE. ANY REPORTED POTENTIAL OR ACTUAL CONFLICTS ARE THEN REVIEWED BY SENIOR MANAGEMENT AND THE AUDIT COMMITTEE, WHEREUPON APPROPRIATE MEASURES ARE TAKEN. ALL EMPLOYEES, BOARD MEMBERS, COMMITTEE MEMBERS AND ADVISORY BOARD MEMBERS ARE REQUIRED TO UPDATE THEIR RESPECTIVE CONFLICT OF INTEREST DISCLOSURES AS NECESSARY DURING THE YEAR. |
| OFFICES & POSITION FOR WHICH PROCESS WAS USED, & YEAR PROCESS WAS | BEGUN FORM 990, PART VI, LINES 15A AND 15B THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS ASSISTS THE BOARD IN OVERSEEING COMPENSATION POLICIES AND BEST PRACTICES. RESPONSIBILITIES INCLUDE OVERSIGHT OF THE COMPENSATION OF THE CHIEF EXECUTIVE OFFICER; THE RANGE OF COMPENSATION LEVELS FOR THE ORGANIZATION'S OTHER OFFICERS, DISQUALIFIED PERSONS, AND OTHER KEY EMPLOYEES; GRANTING THE CHIEF EXECUTIVE OFFICER WITH THE AUTHORITY TO DETERMINE COMPENSATION LEVELS WITHIN AN APPROVED RANGE; AND ANY INCENTIVE/BONUS COMPENSATION PROGRAMS, IF APPROVED. THE CURRENT POLICY WAS ADOPTED IN 2010. A FORMAL COMPENSATION POLICY GOVERNS PAY PRACTICES. PERIODICALLY, ALL POSITIONS IN THE ORGANIZATION ARE REVIEWED AGAINST EXTERNAL MARKET DATA BY ENGAGING INDEPENDENT EXPERTS OR ACQUIRING UPDATED MARKET DATA TO CONDUCT THE BENCHMARKING PROCESS. COMPENSATION IS THEN BASED UPON COMPARABLE MARKET RATES OF PAY WITH CONSIDERATION FOR INTERNAL EQUITY AND THE FINANCIAL POSITION OF THE ORGANIZATION. BENCHMARKING WAS CONDUCTED FOR THE CHIEF EXECUTIVE OFFICER AND ALL EXECUTIVE TEAM MEMBERS' COMPENSATION TO EXTERNAL MARKET DATA IN 2017, TO ENSURE MARKET ALIGNMENT. KOMEN PROVIDES SALARY INCREASES, PROMOTIONS AND OTHER FORMS OF COMPENSATION WITHOUT REGARD TO RACE, COLOR, RELIGION, GENDER, NATIONAL ORIGIN, DISABILITY, VETERAN STATUS OR SEXUAL ORIENTATION. |
| AVAIL OF GOV DOCS, CONFLICT OF INTEREST POLICY, & FIN STMTS TO | GEN PUBLIC FORM 990, PART VI, LINE 19 KOMEN'S FINANCIAL STATEMENTS AND THE FORM 990 ARE PUBLICLY AVAILABLE ON OUR WEBSITE. THE CERTIFICATE OF FORMATION IS AVAILABLE FROM THE TEXAS SECRETARY OF STATE AND OTHER GOVERNING DOCUMENTS ARE MADE AVAILABLE AS REQUIRED BY STATE LAW. FORM 1023 AND THE CONFLICT OF INTEREST POLICY ARE NOT PUBLISHED ONLINE BUT ARE AVAILABLE TO THE PUBLIC UPON REQUEST. |
| ADDITNL DETAIL ON EVENT PRODUCTION EXPENSES INCLUDED ON OTHER EXP | FORM 990, PART IX, LINE 24 KOMEN PAYS 50% OF THE COST OF ALL T-SHIRTS FOR THE 125 SUSAN G. KOMEN RACE FOR THE CURE EVENTS CONDUCTED BY THE KOMEN AFFILIATES DURING THE FISCAL YEAR. |
| OTHER CHANGES IN NET ASSETS OR FUND BALANCES | FORM 990, PART XI, LINE 9 RESCINDED GRANTS $2,093,947 AFFILIATE RACE SERIES DIRECT BENEFIT $ 939,930 ------------ TOTAL $3,033,877 ============ |